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In addressing the pre-mRNA substrate, the splicing machinery requires 
rearrangement of multiple RNA and protein components. The classical model of 
spliceosome formation begins with the U1 snRNA recognition of the 5‟ splice site and 
U2 snRNP interaction with the branch point. This process is followed by the engagement 
of a pre-assembled U4/U6•U5 tri-snRNP to form the A2-1 complex. The spliceosome is 
subsequently activated through a number of structural rearrangements. Among these is 
the unwinding of the U4/U6 intermolecular helix by the tri-snRNP component Brr2p. 
While numerous protein components of the tri-snRNP have been identified, the 
function of many of these remain unknown. The nonessential Snu66p (U4/U6•U5-110K 
in humans) stably associates only with the U4/U6•U5 tri-snRNP while the similarly 
nonessential Snu40p (U5-52K in humans) associates exclusively with the U5 snRNP. To 
understand why two non-essential pre-mRNA splicing factors have been so well 
conserved through great evolutionary distances, we examined their roles in the assembly 
vii 
 
and function of the tri-snRNP. Removal of SNU40 alone does not affect snRNP levels, 
however deletion of SNU66 results in reduced levels of tri-snRNP. The U4/U6•U5 
snRNPs in Δsnu66 cells are resistant to the ATP-dependent U4/U6 unwinding by Brr2p, 
and profound U4/U6 accumulation occurs at reduced temperatures. Remarkably, 
subsequent removal of SNU40 in a Δsnu66 strain bypasses the tri-snRNP formation 
defect while unwinding of U4/U6 remains defective. Additional investigation revealed 
that Prp6p, another tri-snRNP protein, is destabilized from the complex. Based upon this 
data in total, I present a model in which Snu40p and Snu66p interact sequentially with 
Prp6p to maintain directionality for proper biogenesis of the tri-snRNP. 
Further, the U4/U6 unwinding defect of the double mutant should theoretically 
arrest the A2-1 spliceosome. Indeed, native gel analysis confirms the buildup of a large 
complex later determined to be A2-1. I have purified this complex, functionally tested its 
catalytic viability, and identified its components via mass spectrometry. This is the first 
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Chapter 1:  General Introduction 
 
1.1 OVERVIEW OF SPLICING 
1.1.1 Introduction 
It is estimated that up to 30% of human disease causing point mutations affect the 
process of pre-mRNA splicing (Krawczak, Reiss, and Cooper 1992)(Nissim-Rafinia and 
Kerem 2005). While this fact alone would make the process worthy of investigation, the 
field presents potential answers to questions beyond utilitarian disease treatment. 
Although not a defining characteristic of the eukaryotic domain (Yoshinari, 
Takashi Itoh, Hallam, DeLong, Yokobori, Yamagishi, Oshima, Kita, and Yoh-ichi 
Watanabe 2006), the frequency and complexity of splicing seems to correlate with 
evolutionary complexity (Eddo Kim, Magen, and Ast 2007). The genes of many single 
cell eukaryotes often carry a miniscule number of introns while in mammals splicing is 
almost exclusively a requirement. Even beyond the simple intron, however, it appears 
that alternative splicing follows this same trend. There are no known proteins that result 
from an alternatively spliced mRNA in the single celled brewer‟s yeast Saccharomyces 
cerevisiae. In contrast, 2% of proteins result from alternatively spliced mRNA in the 
worm and 7% in the fly (Harrison, Kumar, Lang, Snyder, and Gerstein 2002) It is 
estimated that greater than 50% of all human genes are alternatively spliced (Phillip A. 
Sharp 2005). On the basis of these simple correlations, it would appear that the process of 
mRNA splicing has wide implication in phylogenetics and organism complexity. 
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Nevertheless, it is the complexity of the process itself that has has made the task 
of understanding it so difficult. Indeed, over thirty years of research has yielded only a 
limited understanding of the process. 
1.1.2 History 
In 1977 the work of Phillip Sharp (Berget, C Moore, and P A Sharp 1977), 
Richard Roberts (L T Chow, Gelinas, Broker, and R J Roberts 1977) and colleagues first 
described what was then known as the „split gene‟. Their work compared DNA sequences 
and the mRNA that ultimately resulted from them. It was found that large intervening 
sequences were removed prior to the formation of mature mRNA. These removed RNA 
sequences were later termed „introns‟ by Wally Gilbert (Phillip A. Sharp 2005). 
Similarly, the RNA sections remaining after splicing were termed „exons‟. Soon 
thereafter, the importance of mRNA splicing in human biology was underscored when a 
number of β-thalassemia causing defects were found to be the result of splicing defects 
(Treisman, Orkin, and Maniatis 1983). By the time the existence of the split gene was 
uncovered in the late 1970‟s, the splicing machinery itself had been under investigation 
for over a decade. It wasn‟t until the 1980‟s, however, that it became clear that snRNAs 
and snRNPs were the instrument of mRNA splicing (Lerner, Boyle, Mount, Wolin, and J 
A Steitz 1980). 
1.1.2.1 RNA Component Discovery 
In 1965, Okamura and Busch published an analysis of RNA base composition in 
tissue from Walker 256 rats (Okamura and H Busch 1965). This work noted that whole 
nuclear extract was rich in uridylic acid. This data was quickly followed by a second 
analysis (Muramatsu, James L. Hodnett, and Harris Busch 1966) showing that these U-
RNAs sedimented in a sucrose gradient between 4S-8S. The first of the snRNAs to be 
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isolated were U1, U2, and U3 in 1968 (J L Hodnett and H Busch 1968). During this 
isolation, it was noted that while U1 and U2 were found in the nucleoplasm, U3 was 
restricted to the nucleolus. By the mid-1970‟s, snRNAs (Small Nuclear RNAs) were 
identified and localized (Zieve and Penman 1976) within the HeLa cell. Finally, by late 
1970s and early 1980s most of the snRNAs had been sequenced (U1 (C Branlant, A Krol, 
Ebel, E Lazar, H Gallinaro, M Jacob, Sri-Widada, and Jeanteur 1980),U2 (Shibata, T. S. 
Ro-Choi, R. Reddy, Y. C. Choi, Henning, and H. Busch 1975), U3 (R Reddy, Henning, 
and H Busch 1979), U4 (R Reddy, Henning, and H Busch 1981), U5 (Alain Krol, Helene 
Gallinaro, Eliane Lazar, Monique Jacob, and Christiane Branlant 1981), U6 (Epstein, R 
Reddy, Henning, and H Busch 1980)).  
In 1980 the laboratory of Joan Steitz published work (Lerner, Boyle, Mount, 
Wolin, and J A Steitz 1980) comparing the consensus splice junction sequences with the 
5‟ sequence of the U1 snRNAs. The complementarity naturally led to speculation that 
this RNA species played a role in the splicing process. Also included in this work was 
evidence that U1, U2, U4, U5, and U6 snRNPs were all bound by anti-Sm antibodies as 
well as antibodies from patients with lupus erythematosus. This latter data indicated that 
all five of these snRNAs were involved in the same process. Additionally it was noted 
that U3 was not included in this list. Earlier analysis of U3 demonstrated its ability to 
base pare with the 28S pre-rRNA (Prestayko, Tonato, and H Busch 1970). Thus, it was 
inferred that U3 was not likely to be involved in mRNA splicing but the rRNA 
maturation process (Riedel, Wise, Swerdlow, Mak, and C Guthrie 1986).  
Later work discovered that the process of intron removal utilized a lariat RNA 
intermediate with a corresponding 5‟ exon (Padgett, Grabowski, M M Konarska, Seiler, 
and P A Sharp 1986).  
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1.1.2.2 Protein Component Discovery 
After the discovery of U-RNAs in the mid 1960s, work commenced on the 
identification of interacting partners (H Busch, R Reddy, Rothblum, and Y C Choi 1982). 
It was rapidly recognized that these RNAs were complexed with a number of protein 
components when it was found that protease treatment reduced the RNA sedimentation 
rate (Enger and Walters 1970). These proteins were not isolated, however, until a 1975 
paper on the isolation of the U1 and U2 snRNPs (Raj, Tae Suk Ro-Choi, and Harris 
Busch 1975). The biggest advance to date in snRNP biochemistry came in 1979 with the 
realization that antibodies from human lupus erythematosus patients recognized snRNP 
components (Lerner and J.A. Steitz 1979). This allowed the efficient purification of 
snRNPs and their component snRNAs (Lerner, Boyle, Hardin, and J.A. Steitz 1980). 
1.1.3 General Concepts in Splicing 
1.1.3.1 DEAD/H Box Helicases 
The two transesterification reactions of mRNA splicing do not technically require 
the input of energy. Nevertheless, ATP is required throughout the splicing cycle by the 
helicases responsible for the RNA rearrangements that make splicing possible. These 
helicases appear to be evolutionarily related and share what is known as the DEAD/H 
box domain (Patrick Linder 2006). Four of the proteins share the DEAD box motif: 
Sub2p, Prp5p, Prp28p, Brr2p. (West and Milgrom 2002)(de la Cruz, Kressler, and P. 
Linder 1999)(Patrick Linder 2006). The related DEAH box domain is found in the 
remaining three helicases: Prp2p, Prp16p, and Prp22p (Krainer 1997). While the larger 
class of DExH/D helicases are best known for the ability to unwind RNA-RNA duplexes, 
they also have the ability to perturb RNA-protein interactions (Jankowsky, Gross, 
Shuman, and Pyle 2001).  
 5 
1.1.3.2 snRNP Biogenesis 
The U1, U2, U4, and U5 snRNAs are transcribed by RNA polymerase II, while 
the U6 snRNA is transcribed by RNA Polymerase III. Likely a result of this disparity in 
transcription, the overall biogenesis pathway also differs for U1, U2, U4, and U5 versus 
the Pol III transcribed U6 (Tamas Kiss 2004).  
The snRNAs that result from RNA Polymerase II are immediately capped with a 
monomethyl guanosine cap (m
7
G). This cap attaches to the Cap Binding Complex (CBP), 
which acts as an adapter for the combined PHAX (Phosphorylated Adapter for RNA 
Export) and CRM1/RanGTP export machinery (Ohno, Segref, Bachi, Wilm, and I W 
Mattaj 2000). This complex then shuttles the nascent snRNA from the nucleus via the 
nuclear pore complex. Once in the cytoplasm, the snRNA export complex disassembles 
and the snRNA is addressed by the Survival of Motor Neurons (SMN) complex 
(Massenet, Pellizzoni, Paushkin, Iain W Mattaj, and Dreyfuss 2002)(Paushkin, Gubitz, 
Massenet, and Dreyfuss 2002). This machinery assists the loading of the Sm complex 
protein components onto the Sm binding site of the snRNA. By nature of their common 
biogenesis process, U1, U2, U4, and U5 all share the same Sm protein ring components. 
This group of seven proteins includes Smb1p, Smd1p, Smd2p, Smd3p, Sme1p, SmFp, 
and SmGp which bind to the conserved Sm motif on the snRNAs. The binding of the Sm 
core is a precondition for the activity of the Tgs1p methyltransferase and 3‟ end 
processing (Tamas Kiss 2004). Tgs1p hypermethylates the 5‟ cap to a 2,2,7-
trimethylguanosine (TMG) while it is believed that RNAse III is ultimately responsible 
for cleavage of the 3‟ end to its final state (Chanfreau, S A Elela, Ares, and C Guthrie 
1997). After this post-processing is complete, Snuportin1 works through a importin-β 
dependant mechanism (Palacios, Hetzer, Adam, and I W Mattaj 1997) to the re-import of 
the snRNP into the nucleus (Matera and Shpargel 2006).  
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The biogenesis of the RNA Polymerase III produced U6 snRNA differs from the 
other Pol II produced transcripts, most notably as it is not exported from the nucleus as 
part of its biogenesis. Immediately after transcription U6 is bound by the La protein, 
which is then displaced by the formation of the Lsm protein ring (made of Lsm2p, 
Lsm3p, Lsm4p, Lsm5p, Lsm6p, Lsm7p, Lsm8p) near the 3‟ end of U6. The formation of 
this heptameric ring of Lsm proteins is responsible for U6 transport to the nucleolus 
where the snRNA is methylated (B E Jády and T Kiss 2000) and pseudouridylated 
(Arnold M Kiss, Beáta E Jády, Bertrand, and Tamás Kiss 2004).  
All five snRNAs are adorned with a changing array of protein partners. Some 
proteins have been reported to be exclusive to a single particle, while others remain 
paired throughout the splicing cycle. Table 1.1 lists the proteins that have been identified 
as members of the U1, U2, U4/U6, U5, U6, and tri-snRNP complexes. U4 has not been 
characterized separately from its union with the U6 snRNP. 
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Table 1.1 - Core snRNP proteins 
Data based on (Eurie L Hong et al. 2008)(Krainer 1997)(Alexander Gottschalk, 
Bartels, Gitte Neubauer, Reinhard Luhrmann, and Patrizia Fabrizio 2001)(S.B. Liu, 
Rauhut, H.P. Vornlocher, and R. Lührmann 2006). *Although the localization of yeast 
Prp6p has been a matter of debate, our work in Chapter 3 indicates that it transiently 
interacts with U5 to the exclusion of the U4/U6 snRNP. 
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1.1.4 The Splicing Cycle 
1.1.4.1 Overview 
The two transesterification reactions of the mRNA splicing reaction are driven by 
the formation and remodeling of the spliceosome. As the components are utilized and 
remodeled for future activity, the events form a cycle. The mRNA splicing cycle has 
historically been represented as a stepwise progression of players joining and later exiting 
the substrate mRNA (R.J. Lin, Newman, S.C. Cheng, and J. Abelson 1985). More recent 
data raises the possibility that the spliceosome is formed prior to addressing the substrate 
(Scott W. Stevens, Ryan, Helen Y. Ge, Roger E. Moore, Mary K. Young, Terry D. Lee, 
and John Abelson 2002). In this scenario, the formation and recycling events take place 
as a series of rearrangements rather than physical union and separation. As the newer 
preformed model is addressed later in this work in section 1.1.3.6, this section will review 
the cycle as it is known under the traditional stepwise model. 
During transcription the carboxy-terminal domain (CTD) of RNA polymerase II 
recruits enzymes that create a 7-metyl guanosine cap on the 5‟ end of the nascent pre-
mRNA (Cho, Takagi, Christine R. Moore, and Buratowski 1997)(Fong and Bentley 
2001). After this capping but while transcription continues it is believed that the CTD 
recruits the protein components required for splicing (Listerman, Sapra, and K.M. 
Neugebauer 2006). 
The U1 snRNP binds the 5‟ splice site thus forming the commitment complex. 
The pre-spliceosome or B complex is formed with the ATP dependent addition of the U2 
snRNP (S.C. Cheng and J. Abelson 1987). The addition of U2 is enabled by the splicing 
factor U2AF, which recognizes the polypyrimidine tract between the branchpoint and the 
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3‟ splice site. The addition of a preformed U4/U6∙U5 tri-snRNP completes the A2-1 
complex. A series of ATP and GTP dependent rearrangements result in the unwinding of 
U4 from U6, followed by the release of U1 and U4 from the complex. This frees the 5‟ 
splice site to be addressed by the U6 snRNA which also establishes base pairing with U2 
(D.A. Wassarman and J.A. Steitz 1993). The complex is now referred to as the activated 
spliceosome or A1 complex. The helicase Prp2p causes a rearrangement that leads to the 
A2-2 complex in preparation for the first step of splicing (Silverman, Maeda, Wei, P. 
Smith, J.D. Beggs, and R.J. Lin 2004). The first transesterification reaction leads to the 
A2-3 complex, which contains the lariat intermediate and a free 5‟ exon. The second step 





Illustration 1.1 - The mRNA splicing cycle 
Adapted from Scott Stevens 
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1.1.4.2 The U4/U6 snRNP 
After splicing is completed, the U6 snRNA is recycled where it joins newly 
synthesized U6 in being annealed to the U4 snRNA. The process of reannealing U4 to U6 
requires the Prp24 protein (Rader and Christine Guthrie 2002). The end result of the 
U4/U6 annealing process is a 13S particle containing not only the two snRNAs but the 
proteins Prp3p, Prp4p, Prp31, and Snu13p in addition to the Sm and Lsm core proteins 
(Table 1.1). While the RNA base pairing at the core of this particle no doubt provides a 
good deal of structural integrity, a protein-protein interaction between the human 
homologs of Prp4p and Prp3p have been mapped by co-immunoprecipitation as well 
(Gonzalez-Santos, Anan Wang, Joses Jones, Ushida, Jun Liu, and Hu 2002).  
1.1.4.3 The U4/U6∙U5 tri-snRNP 
Unlike the basepaired U4/U6 di-snRNP, the union of U4/U6 with the 16S U5 
snRNP to create the 25S tri-snRNP does not rely on basepaired interactions. Rather, a 
series of protein-protein interactions is thought to bind the particles together. While the 
structures of U4/U6 and the tri-snRNP remain unsolved, some of the protein-protein 
interactions have been mapped. The most prominent of these interactions is amongst the 
core of the U5 snRNP. The human homologs of Brr2p, Prp8p, and Snu114p form a 
snRNA-free protein complex that has been purified under high salt conditions (T. Achsel, 
Ahrens, Brahms, Teigelkamp, and R. Lührmann 1998). In the years after this discovery a 
number of additional protein-protein interactions have been exposed by co-
immunoprecipitation and two-hybrid experiments. The most recent of these datasets, 
published after the start of this dissertation work, revealed ten additional interactions 
(S.B. Liu, Rauhut, H.P. Vornlocher, and R. Lührmann 2006). The sum of all the data in 
this area is presented in Table 1.2. Although these interactions lack functional 
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verification, some inferences can be drawn. Prp6p and Snu66p are the only identified 
components to have connections with members of the U5 snRNP and U4/U6 snRNP. 
This implies that these two tri-snRNP components might bridge members of the former 
U4/U6 and U5 snRNP components. This hypothesis is both bolstered and made more 
difficult by the statics and dynamics of these proteins. It is widely accepted that Snu66p 
and homologs reside exclusively in the tri-snRNP particle. The mammalian Prp6p 
counterpart, 102K, has been confirmed to be a member of both the U5 and tri-snRNPs. 
Nevertheless, the yeast Prp6p has been reported to be a member of the tri-snRNP and 
U4/U6 snRNP to the exclusion of U5. At the beginning of work for this dissertation the 
reason for this discrepancy was unknown. 
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Table 1.2 – Interactions of the tri-snRNP proteins 
Table uses yeast names for simplicity of comparison. Data from (T. Achsel, 
Ahrens, Brahms, Teigelkamp, and R. Lührmann 1998)(van Nues and Jean D. Beggs 
2001)(Gonzalez-Santos et al. 2002)(Olga V Makarova, Evgeny M Makarov, Sunbin Liu, 
Hans-Peter Vornlocher, and Reinhard Lührmann 2002)(Laggerbauer, Sunbun Liu, 
Evgeny Makarov, Hans-Peter Vornlocher, Olga Makarova, Ingelfinger, Tilmann Achsel, 




1.1.4.4 The A2-1 Complex and Spliceosome Activation 
The A2-1 complex is defined by the presence of all five snRNAs including a 
basepaired U4/U6 in the presence of the substrate pre-mRNA. Two of the U5 snRNP 
proteins that later join the A2-1 complex via tri-snRNP are of particular importance: 
Brr2p and Snu114p. While another U5 protein (Prp8p) is thought to act at the catalytic 
core of the spliceosome (Sontheimer 2001), these two proteins are responsible for the 
unwinding of U4 and U6 to allow for U6 to address the 5‟ splice site. In this function, the 
DEAD box helicase Brr2p is thought to act as the molecular motor to unwind the base 
pairing (Xu, Nouraini, Field, Tang, and Friesen 1996)(Lauber, P. Fabrizio, Teigelkamp, 
Lane, Hartmann, and R. Lührmann 1996)(D. H. Kim and Rossi 1999). In so doing, Brr2p 
appears to be regulated by regulatory G protein Snu114p (Small, Leggett, Winans, and 
Jonathan P Staley 2006). From this standpoint, these two proteins are responsible for the 
events that allow the spliceosome to progress to the activated (A1) spliceosome. 
Concurrent to the actions of Brr2p and Snu114p is the unwinding of U1 from the 
5‟ splice site. This ATP dependent step is executed by the DEAD box helicase Prp28p (J 
P Staley and C Guthrie 1999). This protein has been identified as part of the U5 snRNP 
(S. W. Stevens, Barta, H. Y. Ge, R. E. Moore, M. K. Young, T. D. Lee, and J. Abelson 
2001). In spite of the clear requirement for Prp28p in the A2-1 complex, this protein has 
paradoxically not been identified in purifications of the U4/U6∙U5 tri-snRNP (A. 
Gottschalk, G. Neubauer, J. Banroques, Mann, R. Lührmann, and P. Fabrizio 1999)(S. 
W. Stevens et al. 2001). The purification of the penta-snRNP complex (see section 
1.1.3.6) did, however, contain Prp28p leading to the speculation that previously purified 
tri-snRNP complex exists as either a nonfunctional intermediate or artifact of high salt 
biochemistry (S. W. Stevens et al. 2001).  
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1.1.4.5 The A1 Complex 
After the exit of U1 and U4, the A1 complex is formed. This complex finds a 
bound U6 at the intron of the 5‟ splice site. U6 is concurrently paired to the U2 snRNA, 
which remains bound near the branchpoint. The U5 snRNA is basepaired with the exon at 
the 5‟ splice site (Fantes and Jean Beggs 2000). 
Prp19p and associated proteins (Cef1p, Prp46p, Syf1p, SNT309p, Isy1p, Syf2p, 
CWC2p) are collectively known as the Nineteen Complex (NTC) (Chun-Hong Chen, 
Wan-Chin Yu, Twee Y. Tsao, Lian-Yung Wang, Hau-Ren Chen, Jui-Yen Lin, Wei-Yu 
Tsai, and Soo-Chen Cheng 2002).   The NTC is required for the stable adherence of the 
U5 and U6 snRNPs within the spliceosome (Chan and Soo-Chen Cheng 2005). As part of 
this function, the NTC defines the interaction of the U5 and U6 snRNAs with the 5‟ 
splice site and therefore is a requirement for a properly formed A1 complex. Although it 
is believed that the NTC joins the spliceosome around the time of U4 exit, the order of 
these events was unknown. The purification and characterized of the A2-1 complex 
(Chapter 4 of this work) sheds light on these events. 
1.1.4.6 Transitions to the A2-2 Complex 
    The transition from the activated A1 spliceosome to the A2-2 complex requires 
the activity of the DEAH-box protein Prp2p (King and J.D. Beggs 1990). This ATP 
dependent action moves the 2‟ hydroxyl of the branchpoint adenosine into proximity with 
the phosphodiester bond that composes the 5‟ splice site (S.H. Kim and R.J. Lin 1996). 
1.1.4.7 The A2-3 Complex and Beyond 
After the branchpoint moves into the vicinity of the 5‟ splice site, the first step of 
splicing is initiated – although the exact trigger for this action remains unknown (Fantes 
and Jean Beggs 2000). At this point, the substrate mRNA exists as the 5‟ exon and a 
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lariat intermediate. The formation of the A2-3 complex is not only defined by the 
formation of substrate intermediate, but also by another conformational change within the 
spliceosome. 
In order to prepare for the second step of splicing, the substrate mRNA must 
undergo a rearrangement within the spliceosomal machinery. This rearrangement moves 
the 5‟ splice site into close proximity with its 3‟ counterpart. Both the 5‟ and 3‟ splice 
sites are now bound by the U5 snRNA (Umen and C. Guthrie 1995). The rearrangement 
within the spliceosome is the result of the ATP dependent DEAH-box helicase Prp16p 
(Zhou and Reed 1998). 
In addition to the requirement for Prp16p, additional protein components are 
required for transition to the A2-3 complex. On the other hand, while they are essential, 
the functions of Prp17p, Prp18p, and Slu7p remain less well characterized (Fantes and 
Jean Beggs 2000). 
After the formation of the A2-3 complex, the second transesterification reaction 
occurs rapidly (Fantes and Jean Beggs 2000). Later actions of Prp22p and Prp43p serve 
to release the spliced mRNA (J.D.O. Wagner, Jankowsky, Company, Pyle, and J.N. 
Abelson 1998) and lariat intron (Martin, S. Schneider, and Schwer 2002), respectively. 
The lariat intron is debranched by Dbr1p (Chapman and Boeke 1991) and later degraded. 
1.1.4.8 The Mechanism of the mRNA Splicing Reaction 
It is common speculation that at the core, the spliceosome is a ribozyme 
(Sontheimer 2001). Like most RNA enzymes, the spliceosome requires a divalent ion 
cofactor, likely Mg
2+
 (Villa, Pleiss, and C. Guthrie 2002)(Yean, Wuenschell, Termini, 
and R J Lin 2000). The resulting mRNA splicing reaction occurs in two steps. Both step 
one and step two are transesterification reactions (Alberts, Alexander Johnson, Lewis, 
Raff, Keith Roberts, and Walter 2002).  
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1.1.4.8.1 Chemistry of the First Step 
Step one (Illustration 1.2) of the splicing reaction begins with the attack of the 2‟ 
hydroxyl group oxygen of the branchpoint adenosine on the phosphate at the 5‟ end of 
the intron (Berg, Tymoczko, and Stryer 2006)(Illustration 1.2B). The Mg
2+
 cofactor is 
thought to stabilize the leaving group intermediate in the reaction (Sontheimer 2001). 
This results in the cleavage of the phosphodiester bond between the 5‟ end of the intron 
and the 3‟ end of the upstream exon. Resulting from this process, the branchpoint 
adenosine and 5‟ terminal phosphate are linked by a 2‟,5‟ phosphodiester bond 
(Illustration 1.2C). This molecule is now known as the lariat intermediate (Domdey, 
Apostol, R.J. Lin, Newman, Brody, and J. Abelson 1984). 
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Illustration 1.2 – The first transesterification reaction of mRNA splicing 







1.1.4.8.2 Chemistry of the Second Step 
The second step of the splicing reaction starts with the intermediate A2-2 complex 
(Illustration 1.3A). With the conformational change to the A2-3 complex, the 5‟ and 3‟ 
splice sites are moved into close proximity. The hydroxyl group located on the 3‟ end of 
the 5‟ exon attacks the phosphodiester bond between intron and 3‟ exon (Illustration 
1.3B). This results in a completely excised lariat intron and linked exons (Illustration 




Illustration 1.3 – The second transesterification reaction of splicing 







1.1.4.9 Assembly Models: Stepwise Versus Preformed 
Although the model presented in Illustration 1.1 is based on a stepwise    
association of snRNPs to the pre-mRNA, there has recently been some debate as to the 
accuracy of this paradigm. Specifically, significant data exists that the spliceosome may 
assemble in absence of a substrate (Scott W. Stevens et al. 2002). Under this hypothesis, 
the progression of steps seen in Illustration 1.1 are not the result of component entry and 
exit, rather, each step simply represents a rearrangement of preexisting components. 
The preformed model is the result of data indicating that spliceosomal component 
stability is highly salt sensitive. While characterizing the tri-snRNP (Scott W. Stevens 
and John Abelson 1999) under 250mM KCl purification conditions, Stevens et al noted 
that decreased salt concentrations of 150mM resulted in the purification of a 30S 
U2∙U4/U6∙U5 tetra-snRNP (unpublished data, noted in (Scott W. Stevens et al. 2002)). 
This work echoed previous findings in the mammalian system (M.M. Konarska and P.A. 
Sharp 1988) where the pre-mRNA free particle was termed the pseudospliceosome. 
Pursuing a further reduction in KCl concentrations to the physiological level of 50mM, 
Stevens and associates found that in addition to the tetra-snRNP, a 45S particle consisting 
of all five snRNAs was purified. Further, this particle was found to be missing the pre-
mRNA binding proteins indicative of a substrate.  
This data led to the alternative hypothesis that the spliceosome is a 45S RNP that 
is comprised of all five snRNAs. This complex is preformed in absence of a substrate 
pre-mRNA. In the event that a singular U1 snRNP should commit the pre-mRNA to 
splicing, a tetra-snRNP is recruited to form a functional A2-1 complex. Figure 1.4 
represents this model.  
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In the period after the genesis of this model, there has been data both confirming 
and conflicting with the penta-snRNP model. Data from the mammalian system not only 
confirms the existence of a preformed spliceosome (Malca, Shomron, and Ast 
2003)(Azubel, S.G. Wolf, J. Sperling, and R. Sperling 2004), but builds upon this model 
with the formation of a supraspliceosome (Azubel, Habib, R. Sperling, and J. Sperling 
2006). This complex, which sediments at 200 S (Svedbergs) in a glycerol gradient, 
complex is thought to result from the engagement of four preformed spliceosomes onto a 
substrate mRNA. The supraspliceosome model was later confirmed by work in both 
HeLa cells as well as the DT40 chicken model (Yen-I G Chen, Roger E Moore, Helen Y 
Ge, Mary K Young, Terry D Lee, and Scott W Stevens 2007).  
On the other hand, there have been a number of publications supporting the 
stepwise model of assembly. An analysis of cotranscriptional spliceosome formation in 
Saccharomyces cerevisiae revealed that a perturbation of the cap binding complex results 
in the spliceosomal loss of U5 on some transcripts while U1 andU2 snRNPs are retained 
(Görnemann, Kotovic, Hujer, and Karla M Neugebauer 2005). This data was later 
replicated using chromatin immunoprecipitation to address the spliceosomal assembly 
(Tardiff and Rosbash 2006). Lastly, analysis of HeLa extract indicates that U1 and U2 are 
able to form functional pre-spliceosomes independently of the U4/U6∙U5 tri-snRNP or 
indeed the penta-snRNP complex (Behzadnia, Hartmuth, Cindy L. Will, and Reinhard 
Luhrmann 2006).  
It is perhaps noteworthy that none of the findings have formally ruled out either 
pathway as inviable. Nor has the kinetic favorability of each respective model been 
addressed. In the end, it is a possibility that spliceosome assembly is achievable under 
both models, with one being the favored on pathway route under in vivo conditions.  
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For the sake of simplicity, I will use the traditional model of stepwise assembly 
throughout the remainder of this work to address the background of spliceosome 





Illustration 1.4 – The penta-snRNP model of spliceosome assembly 
Adapted from (Scott W. Stevens et al. 2002). 
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1.2 SACCHAROMYCES CEREVISIAE AS A MODEL ORGANISM 
1.2.1 General 
1.2.1.1 History 
It can be said that yeast are the original biotechnology product as humans have 
been employing various species for more than 8,000 years in the production of beer 
(Thomas 2007). In spite of their widespread use, it wasn‟t until Anton van Leeuwenhoek 
first described yeast cells the late 17
th
 century that their existence became known 
(Kornberg 1989). The link between the biochemical process of fermentation and yeast 
wasn‟t made until Pasteur‟s seminal work “Etudes sur la Biere” was published in 1876 
(Baron 1996). Finally, in 1897, Eduard Buchner described the successful fermentation of 
a cell-free yeast extract. In many ways, this work represents the birth of modern 
biochemistry (Kornberg 1989). In the years following this discovery, the enzymes 
responsible for this activity were isolated. Although utility was found in other model 
organisms, yeast has retained its position as one of the preeminent models for study. 
Although there are more than 1500 known species of yeast, brewer‟s yeast or 
Saccharomyces cerevisiae remains the most widely characterized. 
Over the past century, numerous biochemical and genetic techniques have been 
developed for use with yeast. No doubt a result of this toolkit, the complete genome of S. 
cerevisiae was published in 1996 (Goffeau et al. 1996). As the first eukaryote to be fully 




Yeast has a rapid doubling time, on order of two hours for a wildtype strain. It is 
relatively inexpensive to maintain and grow, and is easily archived in glycerol at -80°C. 
Saccharomyces cerevisiae readily undergoes homologous recombination, thus allowing 
for the insertion of exogenous sequences with ease (D Botstein and GR Fink 1988). The 
selection of these insertions is made uncomplicated by the existence of a chemically 
defined media and library of auxotrophs (Sherman 1991). A haploid phase allows 
recessive alleles to be altered without the complications found in diploid species. All of 
these features have resulted in an abundance of knowledge about this biological system 
and the techniques pertinent to it. The full sequencing of the genome revealed that the 
system operates on a modest 6000 genes, with none of the complications that result from 
alternative splicing. 
1.2.1.3 Disadvantages 
The disadvantages of Saccharomyces cerevisiae as a model organism all spring 
from its relative simplicity and evolutionary distance from humans. Being a single cell 
organism, it has inherent limitations in uncovering discoveries relevant to the human 
model. Nevertheless, the prime disadvantage of Saccharomyces cerevisiae as a model 
system for the study of RNA splicing, however, stems from the limited activity of this 
system. Perhaps due to the relative modest number of introns present in the organism, the 
number of active spliceosomes is somewhat limited in comparison to mammals. The 
result of this is that a fair amount of cell mass is needed for biochemical analysis, often 
requiring agitated fermentation. Nevertheless, in spite of the challenges of the system the 
advantages of Saccharomyces cerevisiae have made it the premier model for the study of 
mRNA splicing. 
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1.2.2 The Yeast Spliceosome as a Mammalian Model 
Of the six thousand genes in Saccharomyces cerevisiae, only 283 contain introns. 
As there are only 296 introns present in the genome, the vast majority of genes that are 
spliced contain only a single intron of on average less than 500 nucleotides in size 
(Parenteau et al. 2008). These introns seem to be nonrandomly distributed, with 70% of 
ribosomal protein encoding genes undergoing splicing (Fantes and Jean Beggs 2000). 
Paradoxically, the vast majority of yeast introns appear to be nonessential for growth. A 
recent study found that the deletion of 96 separate introns (33% of all yeast introns) led to 
lethality in only five cases (Parenteau et al. 2008). 
In contrast to yeast, the average human gene contains nine exons. Internal exons 
are 145 nucleotides long on average, with introns that are a mean of 3300bp long (Lander 
et al. 2001). Moreover, mammalian introns are known to contain biologically active 
elements like snoRNAs (Small nucleolar RNAs) within (Parenteau et al. 2008). 
Perhaps owing to the increased complexity requirements, the mammalian system 
has been found to have two distinct spliceosomal systems (Woan-Yuh Tarn and Joan A. 
Steitz 1997). In addition to the traditional system composed of the U1, U2, U4, U5, and 
U6 snRNPs, mammals have been found to contain an alternative system referred to the 





 while sharing U5 with the traditional U2-specific system (Luo, 
Moreau, Levin, and M J Moore 1999). (As this focus of this research is on the yeast 
spliceosomal system, all comparisons to the mammalian system will be with the 
traditional U2 spliceosome to the exclusion of the ATAC spliceosome.) 
At the top level, the differences between mammalian and Saccharomyces 
cerevisiae splicing appear to be vast. Nevertheless, decades of work has revealed a great 
deal of conservation in the spliceosome itself. While and all five snRNA homologs were 
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identified early (C Guthrie and Patterson 1988), the subsequent years have revealed an 
array of proteins serving similar functions. 
1.2.2.1 mRNA 
Sequence conservation is much more strict in Saccharomyces cerevisiae than in 
mammals (Fantes and Jean Beggs 2000). With the exception of the leading nucleotides 
GU, the mammalian 5‟ splice site intron sequence is variable. The yeast sequence is more 
consistently a GUAUGU sequence (Sunbin Liu 2005). The branchpoint sequence is 
similarly comparable, with a highly conserved yeast sequence and a more variable 
mammalian. The 3‟ splice site sequence is rather short in both cases. 
Overall, the greater variability of splice sequence in mammals is thought to enable 
alternative splicing (Fantes and Jean Beggs 2000). As Saccharomyces cerevisiae has no 
such requirements, a strict consensus splice site signal is probably favorable, both 






Illustration 1.5 – S. cerevisiae and metazoan consensus splice sequences  
R represents any purine, while Y represents any pyrimidine. Sequences in bold 





Excepting U6, snRNA length and primary sequence is widely divergent across 
species (Fantes and Jean Beggs 2000). On the other hand, the U6 sequence is highly 
conserved (Fantes and Jean Beggs 2000). The yeast U5 is alternatively processed at the 
3‟ end to result in two final, active versions of the snRNA (Chanfreau, S A Elela, Ares, 
and C Guthrie 1997). The purpose of these two forms has not been elucidated to date. 
While the difference in size between yeast and humans is particularly large in the U1 and 
U2 snRNAs, the yeast U1 snRNA specifically contains additional domains that have no 
mammalian counterpart. It has been noted that the yeast U1 snRNP contains seven 
proteins that have no known mammalian counterpart. The presumption is that the 
existence of extra domains in the snRNA and the additional proteins are linked to U1 
functionality in yeast that the mammalian counterpart lacks. Although the function of 
these players remains unproven, speculation exists that they are responsible for 5‟ splice 
site selection in an organism that does not require the flexibility of SR protein based 
enhancer selection (Fantes and Jean Beggs 2000).  
In spite of the differences in primary sequence, the snRNA secondary structure is 
well conserved between yeast and mammals (Birnstiel 1988). The polymerase II products 
of both species contain Sm binding domains, and similarly contain Lsm binding regions 





snRNA Gene Size (nt) Size (nt)
U1 SNR19 568 164
U2 SNR20 1175 187
U4 SNR14 160 145
U5S SNR7 179 -
U5L SNR7 214 116




Table 1.3 - Comparison of yeast and mammalian snRNAs 
In every instance, the snRNAs of Saccharomyces cerevisiae are larger than their 





The first ten snRNP proteins were purified from rat tissue in 1975. Since this 
time, scores of proteins have been identified that are either essential or advantageous for 
spliceosome function. Nevertheless, it was in probing these functional questions that the 
limitations of mammalian systems became apparent. As noted above in section 1.2.1.2, 
Saccharomyces cerevisiae as a model organism presents a number of advantages with 
regard to the practice of genetics. Ease of creating gene knockouts, epitope tagging, and 
rapid doubling time resulted in the ability to probe genetic interactions that weren‟t 
possible in mammalian counterparts.  
Over time, spliceosomal proteins have been identified in both systems. Many of 
these have been found to be functional and structural homologs. Unfortunately, the 
protein naming conventions do not make these partners in homology readily apparent. To 
ease in discussion of these systems in later chapters, a table of known homologs is 






1.3 AFFINITY PURIFICATION AND SEPARATION METHODS 
1.3.1 The Tandem Affinity Purification 
The Staphylococcus aureus protein-A has long been utilized in the laboratory to 
purify IgG antibodies and associated antigens (Kessler 1975). This protein binds 
antibodies rapidly with high affinity. While protein-A fusions were in use prior to the late 
1990‟s (Popplewell, Gore, Scawen, and Atkinson 1991)(Stirling, Petrie, Pulford, 
Paterson, and Michael J. R. Stark 1992), it wasn‟t until 1999 that this tool was widely 
utilized. The advent of the Tandem Affinity Purification (TAP) tag allowed for the two 
step purification of protein complexes under native conditions (Rigaut, Shevchenko, 
Rutz, Wilm, Mann, and Séraphin 1999). Whether the tag sequence is attached to the C 
(Rigaut et al. 1999) or N (Puig, Caspary, Rigaut, Rutz, Bouveret, Bragado-Nilsson, 
Wilm, and Séraphin 2001) terminus of the bait protein‟s genome sequence, options exist 
to insure accessibility and avoidance of steric interactions. The tag consists of a protein-A 
domain and a calmodulin binding domain separated by a Tobacco Etch Virus (TEV) 
protease cleavage site. This configuration allows a primary purification using IgG 
sepharose beads. The protein and associated complex is then eluted under identical buffer 
conditions through cleavage of the TEV protease at the target sequence (Dougherty, 
Cary, and Parks 1989). The second affinity step can then utilize the calmodulin binding 
domain (Niggli, Penniston, and Carafoli 1979) Washing the protein complex while bound 
to the calmodulin sepharose removes additional contaminants as well as the TEV 
protease used for elution from the first step. Elution from the calmodulin sepharose beads 
requires removal of free Ca
2+
 from the buffer solution. This is typically achieved through 
use of ethylene glycol tetraacetic acid (EGTA) as a chelating agent. It is noteworthy that 
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EGTA not only binds calcium, but also free magnesium. This is an important 
consideration when purifying RNPs that require Mg
2+
 for proper RNA folding as the 
removal of this ion often dissolves the particle. 
1.3.2 The Glycerol Gradient 
As one of one of the most established biochemical separation techniques (Brakke 
1953), the density gradient has been well established as a prime method for separation of 
particles by size and mass. The sedimentation coefficient in Svedberg units (S) has been 
assigned to most cellular components, thus allowing for easy comparison of particle size 
(Berg, Tymoczko, and Stryer 2006). More recently, the glycerol gradient has gained 
favor in the separation of spliceosomal complexes. Established gradient conditions allow 
for the rapid separation of mono-snRNPs from the U4/U6 di-snRNP, and tri-snRNP 
(Scott W. Stevens and John Abelson 1999), while alternate conditions must be considered 
for fully assembled spliceosomes (Scott W. Stevens et al. 2002). 
1.4 MASS SPECTROMETRY AS A METHOD OF IDENTIFYING PROTEINS 
The beginnings of mass spectrometry as a field of research stretch back over a 
century (Thompson 1907). As an analytical technique, it found use beginning in 1919 
determining atomic weights (Borman, Russell, and Siuzdak 2003). Due to difficulties in 
ionizing highly polar peptides, it wasn‟t until the 1980‟s that the field was sufficiently 
advanced for use in the biosciences (Mann, Hendrickson, and Pandey 2001). The 
development of matrix-assisted laser desorption/ionization (MALDI) and electrospray 
ionization (ESI) along with automated spectra analysis enabled the use of the mass 
spectrometry to identify short peptide sequences. 
A combination of technologies is utilized in the gathering of mass spectrometric 
data. These technologies can broadly be grouped into two categories: ionization method 
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and the mass spectrometric instrumentation itself. While there are two dominant 
techniques for ionization of peptides, there are multiple types of instrumentation in 
popular use. Formally all three of these instrumentation techniques could be used 
independently with either ionization technique. In practice, however, MALDI is usually 
paired with time of flight (TOF) analysis.  Likewise, ESI has been popularly paired with 
quadrupole and ion-trap spectrometers. 
Matrix-assisted laser desorption/ionization was paired with time of flight analysis 
(MALDI-TOF) to create a system that ionizes sample via laser excitation then identifies 
the mass to charge ratio based on the time of flight to a detector (Karas and Hillenkamp 
1988). Once created, the ions are driven to the detector through use of an acceleration 
field by way of an ion mirror that corrects for differences in initial energy.  
Like all techniques, MALDI-TOF has both advantages and disadvantages when 
compared to competing technologies (Carr, Hemling, Bean, and Gerald D. Roberts 1991). 
Among its strengths are the relative simplicity of the system and the insensitivity to salts. 
The disadvantage of low resolution limits is more often overshadowed by the inability to 
be easily paired with liquid chromatography. 
At one time, multiple charge states complicated the interpretation of electrospray 
ionization data (Carr, Hemling, Bean, and Gerald D. Roberts 1991). As computational 
horsepower has increased this limitation has subsided and ESI has become the dominant 
ionization method used in peptide identification. This technique pumps the sample 
through a fine needle so that micrometer sized droplets are ejected with help of an inert, 
nebulising gas into the charged spectrometer field (Yamashita and Finn 1984). Once in 
flight, the ion is commonly analyzed by spectrometry in the quadrupole and ion trap 
configuration (Fenn, Mann, Meng, S F Wong, and Whitehouse 1989). Quadrupole 
detection results from the generation of an electric field from four rods. This field acts as 
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a mass filter, allowing for the detection of ions of a given mass. The scanning of the field 
then allows the detection of a range of masses (Mann, Hendrickson, and Pandey 2001). 
Ion trapping allows the stream of ions to be captured and then later ejected by the 
alteration of a magnetic field (Mann, Hendrickson, and Pandey 2001).    
Although not strictly confined to use with ESI, tandem mass spectrometry has 
been paired with ESI to great effect (Biemann and Scoble 1987). This technique pairs 
two spectrometers together to achieve greater resolution than would be possible with a 
single detector. Briefly, after detection in the first spectrometer, molecules are routed into 
a collision chamber where they are fractured by contact with an inert gas. The fragments 
of the peptide are then identified in a second detector followed by computational analysis 
that cross references data from the primary detection with the secondary.  
For numerous reasons, ESI-MSMS has become the most popular technique set for 
peptide analysis. One of the advantages of ESI is the ability to pair it with one or more 
liquid chromatography steps. This allows for the separation of a complex peptide mixture 
prior to introduction into the analytical equipment. The most promising variant to utilize 
ESI is termed Automated Ultra-High-Pressure Multidimensional Protein Identification 
Technology (UHP-MudPIT) (Motoyama, Venable, Ruse, and John R Yates 2006). This 
system analyzes a trypsinized protein sample via a two dimensional chromatography 
separation prior to introduction to ESI. The first separation relies on a strong cation 
exchange column. The second separation utilizes a reverse phase gradient. Detection 
relies on tandem mass spectrometric analysis. 
1.5 DISSERTATION OBJECTIVES 
The goals of this project were originally quite different than what the end result 
became. The project began as an attempt to prepare the U5 and tri-snRNPs for cryo-
electron microscopy. To achieve this goal, the complex to be purified would need to be 
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completely homogenous. These Saccharomyces cerevisiae complexes contain two 
different isoforms of Snu40p and Snu66p, as well as the long and short versions of the 
U5 snRNA. With this in mind, I set out to create a double Δsnu40 / Δsnu66 knockout 
strain. When this strain was created, however, I noted that the double deletion resulted in 
a slight growth defect at lower temperatures. Serial dilutions incubated at a range of 
temperatures later confirmed this defect. Later molecular analysis revealed the tri-snRNP 
formation and function defects that became the basis of this dissertation. As is so often 
the case in science, serendipity and vigilance ruled the day. 
This work is divided into four chapters. Chapter one provides a synopsis of the 
spliceosome, its component parts, and the splicing reaction these components drive. The 
chapter also compares Saccharomyces cerevisiae as a model organism against the 
benchmark of mammalian cell culture. Lastly, the chapter reviews the methods of protein 
complex purification, separation, and mass spectrometric analysis.   
Chapter two details the materials and methods used throughout this work. The 
chapter begins with a listing of plasmids, strains, DNA oligonucleotides, and equipment 
used generally throughout. The next two sections detail the methods and materials used 
specifically for the work in chapters three and four. 
Chapter three details the effects of a deletion of SNU40 and SNU66 from the yeast 
genome. The section shows that a double deletion of SNU40 and SNU66 leads to 
synthetic lethality at 16°C. Later work shows the effect of these deletions, as a singularly 
and in concert, on tri-snRNP formation. Lastly, this section reveals that the double 
deletion strain creates tri-snRNP that is deficient in U4/U6 unwinding activity at low 
temperatures. This inability to unwind U4 from U6 likely stalls the spliceosome at the 
precatalytic stage and leads to the synthetic lethality seen at restrictive temperatures. 
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Chapter four builds upon the previous chapter by purifying and characterizing the 
precatalytic spliceosome. The double knockout mutants used in chapter four revealed a 
buildup of a large complex at restrictive temperatures. This chapter uses affinity 
purification to isolate this complex. Consistent with the precatalytic spliceosome, 
northern blotting identifies the complex as containing all five snRNAs. Mass 
spectrometric analysis reveals the identity of numerous protein components present. 
Lastly, it is revealed that this precatalytic spliceosome is capable of catalytic activity. 
Taken together, these results achieve at least three objectives. Firstly, the function 
is determined for the nonessential proteins Snu40p and Snu66p. Secondly, the functional 
proof and importance of Prp6p as a bridging factor between the U4/U6 di-snRNP and the 
U5 snRNP is emphasized. Lastly, a catalytically active precatalytic spliceosome has been 
purified and characterized in Saccharomyces cerevisiae. The dataset resulting from this 
characterization has implications for numerous aspects of the splicing cycle. 
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Chapter 2:  Methods and Materials 
2.1 PLASMIDS GENERALLY USED 
pBS1479 (Puig et al. 2001) and pBS1365 (Puig et al. 2001) were used in the 
creation of TAP tagged strains. pMPY-2xMYC (B L Schneider, Seufert, Steiner, Q H 
Yang, and Futcher 1995) was employed to make gene knockout constructs. Both are 
described in greater detail in subsequent sections. 
2.2 YEAST STRAINS GENERALLY USED 
 
 
Table 2.1 – Yeast strains used throughout 
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2.3  DNA OLIGONUCLEOTIDES GENERALLY USED 
Table 2.2 – DNA oligonucleotides used throughout 
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2.4  EQUIPMENT GENERALLY USED 
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2.5 METHODS AND MATERIALS SPECIFICALLY USED IN CHAPTER 3 
2.5.1 Yeast growth and plasmids 
Yeast were cultured on YPD or dropout media as required (Sherman 1991). 
Plasmids used were pMPY-2xMYC (B L Schneider, Seufert, Steiner, Q H Yang, and 
Futcher 1995) for URA3 popout knockouts, pBS1479 for TAP-tagging (Puig et al. 2001), 
pTAP-URA3 was created by subcloning the NotI/ApaI fragment of pBS1365 (Puig et al. 
2001) into NotI/ApaI digested pBS1479 to allow TAP tagging with a URA3 marker.  
2.5.2 Generation of Knockout Strains 
BY4734 (MATα, his3Δ200, leu2Δ0, met15Δ0, trp1Δ63, ura3Δ0) was used as the 
parent of all strains. All knockouts were created through use of a PCR-generated 
replacement fragment containing 50 bp. arms of homology to the desired knockout region 
and a URA3 marker bounded by direct repeats (B L Schneider, Seufert, Steiner, Q H 
Yang, and Futcher 1995). Ura+ colonies were screened by PCR to determine the correct 
targeting following transformation using the lithium acetate procedure (Gietz and Woods 
2002). Correctly targeted strains were subjected to 5-FOA-containing media to remove 
the URA3 (Boeke, Trueheart, Natsoulis, and G.R. Fink 1987). Double deletions were 
generated by removal of the second gene following the 5-FOA treatment of the first. 
2.5.3 Generation of Affinity Tagged Strains 
BY4734, ySS1034 (∆snu40), ySS1036 (∆snu66), and ySS1038 (∆snu40/∆snu66) 
were used as parent strains for the creation of TAP tagged Prp6p strains using pTAP-
URA3: ySS2013 (BY4734 PRP6-TAP::URA3), ySS2014 (ySS1034 PRP6-TAP::URA3), 
ySS2015 (ySS1036 PRP6-TAP::URA3), ySS2016 (ySS1038 PRP6-TAP::URA3). 
Similarly, these parent strains were used in the creation of Brr2p-TAP strains ySS2017 
(BY4734 BRR2-TAP::URA3), ySS2018 (ySS1034 BRR2-TAP::URA3), ySS2019 
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(ySS1036 BRR2-TAP::URA3), and ySS2020 (ySS1038 BRR2-TAP::URA3). Properly 
TAP-tagged strains were confirmed using western blotting with peroxidase-
antiperoxidase complex (Rockland). 
2.5.4 Extract Preparation 
All cultures were grown in a volume of 1.5 L of YPD at 31°C unless otherwise 
noted. Strains grown at cold temperatures were grown to OD600=0.5 before chilling in 
ice water and shifting to 19°C for additional growth. Cells were then harvested at an OD 
(A600) of ~ 1.5 prior to processing. Briefly, cells were washed once in ice-cold ultrapure 
water, then washed a second time in 35 ml of AGK buffer (10 mM HEPES pH 7.9, 1.5 
mM MgCl2, 200 mM KCl, 0.5 mM DTT, 10% glycerol) (Ansari and Schwer 1995). 
After the second wash, cells from 1.5 L were resuspended in 7 ml of AGK and frozen 
dropwise in liquid nitrogen prior to storage at -80°C. Cells were disrupted in a Retsch 
MM300 mill in liquid nitrogen using five cycles of three minutes each at 10 Hz. After 
thawing, the extract was clarified by centrifugation at 30,000 x g for 30 min at 4°C. The 
extract was centrifuged a second time at 100,000 x g for 1 hour at 4°C. The extract was 
then dialyzed in twice in 2 L of Buffer D (20% glycerol, 20 mM HEPES pH 7.9, 0.2 mM 
EDTA, 50 mM KCI, 0.5 mM DTT) for 1.5 hours at 4°C. The extract was centrifuged for 
10 min at 20,000 x g and frozen at -80°C. 
2.5.5 Serial Dilutions 
Cultures were grown to between OD (A600) ~1.5 and diluted to OD (A600) 1.0. 
Subsequent ten-fold serial dilutions were made using sterile water. All dilutions were 
made on synthetic complete medium + 2% glucose. 
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2.5.6 Native Gel snRNP Analysis 
Extracts (3 µl) were loaded to 1.5 mm thick native gels (4% polyacrylamide 
[80:1], 50 mM Tris base, 50 mM glycine, 2 mM MgCl2) (Raghunathan and C. Guthrie 
1998a). Gels were electrophoresed at 160 V for 6 hours at 4°C with recirculating buffer. 
Where indicated, extracts were supplemented on ice with ATP or ATP+GTP, to the 
indicated concentrations and incubated at 19˚C or 31°C for 10 minutes prior to loading. 
2.5.7 Denaturing RNA Gel Analysis 
RNA was electrophoresed at 15 mA for 3 hours on a 20x16x1 mm denaturing 
polyacrylamide gel (7% acrylamide [19:1] 8M urea, 1 X TBE) (S.W. Stevens and J. 
Abelson 2002). This gel was then used in Northern analysis, gel extraction, or ethidium 
bromide visualization, depending on the application. 
2.5.8 Northern Blotting 
The gel was transferred overnight at 10 V and 4°C onto Brightstar membrane 
(Ambion) in an electroblotting apparatus (BioRad) in 25 mM sodium phosphate pH 7.0. 
After UV crosslinking for 30 sec, the membrane was placed into church buffer ((G.M. 
Church and W. Gilbert 1984) [7% SDS, 500 mM NaPO4 pH 7.0, 1 mM EDTA]). Pre-
hybridization was performed for a minimum of 30 minutes at 42°C with rotation. 
Hybridization with γ-32P radiolabeled oligonucleotides was performed overnight at 42°C. 
The membrane was then washed briefly with 6x SSC. Two 15 minute washes were then 
performed in 2x SSC containing 0.5% SDS prior to a short 6x SSC wash. The membrane 
was then exposed overnight to a Bio-Rad phosphorimaging screen. The screen was 
developed in a GE Healthcare Typhoon phosphorimager. 
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2.5.9 Western Analysis 
Protein samples were electrophoresed on 1 mm 17 well Invitrogen NuPAGE gels. 
Overnight transblotting was performed at 25V at 4°C in transfer buffer [20% methanol, 
3.5 mM SDS, 386.3 mM glycine, 239.4 mM Tris base] to a nitrocellulose membrane 
(BioRad). The sample was then blocked for 1 hour in BLOTTO [5% dry milk in PBST 
(phosphate-buffered saline containing 0.2% Tween-20)]. After two 5-minute washes in 
PBST, the membrane was probed with peroxidase anti-peroxidase complex (rabbit; 
Rockland) in BLOTTO. The membrane was then washed 4 times with PBST for 15 
minutes each. Enhance chemiluminescent detection was performed to detect the western 
blot signal (Perkin Elmer)  
2.5.10 U4/U6 Unwinding Assay 
20 µl of the indicated extract was mixed with 10 µl of IgG sepharose [10µg/µl 
IgG] in 200 µl NET50 buffer [50 mM Tris-Cl pH 7.4, 0.05% NP-40, 50 mM 
NaCl](Raghunathan and C. Guthrie 1998a). The mixture was rotated for 1.5 hours at 4°C 
and washed 3 times with 500 µl NET50. Identically prepared “E” samples in Figure 3.5 
were stripped of RNPs with 400 µl of 1% SDS at this stage to demonstrate the total 
amount of U4, U5, and U6 bound to the beads. To prepare the supernatant “S” samples, 
washed beads were incubated for 5 minutes in 30 µl of unwinding buffer [2.5 mM 
MgCl2, 3% PEG-8000, 60 mM potassium phosphate pH 7.5, 8% glycerol, 8 mM HEPES 
pH 7.9, 0.08 mM EDTA, 20 mM KCl, 0.2 mM DTT]. Either ATP or the combination of 
ATP and GTP were added to a final concentration of 2 mM. The samples were incubated 
for 5-minutes at 11°C. The supernatant “S” was removed and the remaining affinity 
matrix was washed once with 350 µl NET50. This wash was combined with the 30 µl 
unwinding buffer as the total “S” sample. The beads were then stripped of remaining 
RNPs with 400 µl 1% SDS and constituted the beads “B” sample. All samples were 
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phenol chloroform extracted and the nucleic acids precipitated with 2.5 volumes of 100% 
ethanol at -30°C overnight. 
2.5.11 Whole-Cell Extract Gradients 
Strains ySS2013, ySS2014, ySS2015, and ySS2016 were grown at 31˚C, chilled 
in ice water and shifted to 19˚C prior to harvesting as described above. Extracts from 
were made as described above. After thawing on ice, 80 µl of cell extract was added to 
120 µl of buffer GG [20 mM HEPES pH 7.0, 100 mM KCl, 0.2 mM EDTA, 5 µM 
Leupeptin, 3 µM Pepstatin, 0.4 mM PMSF, 0.5 mM DTT]. The mixture was layered onto 
a 10%-30% glycerol gradient and sedimented at 4˚C for 18 hours at 103,847 x g in an 
SW41 swinging bucket rotor. The gradients were harvested in 400 µl fractions, which 
were phenol-chloroform extracted. RNA and protein fractions were then precipitated 
overnight at -30° (S.W. Stevens and J. Abelson 2002). 
2.5.12 Prp6p-TAP Affinity Purification 
Extracts from strains ySS2013, ySS2014, and ySS2015, were prepared as 
described above except that extracts were dialyzed in Buffer D-Light (8% glycerol, 20 
mM HEPES-KOH, pH 7.9, 0.2 mM EDTA, 50 mM KCI, 0.5 mM DTT.) Dialysis was 
performed twice for 1 hour each resulting in 5 ml of extract, which was then incubated 
with 250 µl of IgG agarose beads for 30 minutes at 4°C with rotation. The affinity-
purified material was washed with 100 ml of Buffer D-Light. The beads were transferred 
to a microfuge tube and incubated with 400 µl Buffer D-Light containing 6 µg TEV 
protease for 1 hour at 17°C with rotation. The beads were harvested by centrifugation and 
the supernatant was layered onto a 10%-30% glycerol gradient. This was sedimented at 
169,044 x g for 14 hours at 4°C in an SW41 rotor prior to fractionation, RNA extraction 
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and precipitation. RNA samples were electrophoresed through a denaturing urea-PAGE 
gel and northern blotted (see above). 
2.6 METHODS AND MATERIALS SPECIFICALLY USED IN CHAPTER 4 
2.6.1 Extract Preparation for use in Affinity Purification 
1.5L cultures grown at 31°C were used unless otherwise noted. Cultures were 
grown to OD600=0.5 before temperature shifting the incubator to 19°C for additional 
growth. Once the cultures reached an OD (A600) of ~ 1.5, they were harvested and 
processed as has been documented elsewhere. Briefly, cells were initially washed in 4°C 
ultrapure water. A second wash in 35 ml of AGK buffer (10 mM HEPES pH 7.9, 1.5 mM 
MgCl2, 200 mM KCl, 0.5 mM DTT, 10% glycerol) was then executed. Lastly, the cell 
pellet was resuspended in 7 ml of AGK and frozen in liquid nitrogen. Long-term storage 
occurred at -80°C. Cell disruption was executed in a Retsch MM300 mill with 50ml 
canisters immersed in liquid nitrogen using five cycles of three minutes each at 10 Hz. 
The powdered, lysed cell material was then stored up to one week at 80°C. After thawing 
the material quickly in room temperature water, the cell debris was pelleted by 
centrifugation at 30,000 x g for 30 min at 4°C. A second centrifugation step of the 
resulting supernatant at 100,000 x g for 1 hour at 4°C cleared the extract. Extract was 
dialyzed twice in 2 L of Buffer D-Light (8% glycerol, 20 mM HEPES pH 7.9, 0.2 mM 
EDTA, 50 mM KCI, 0.5 mM DTT) for 1.5 hours each at 4°C.  
2.6.2 IgG-Protein A Purification 
Once dialysis of the extract was complete, it was incubated with 200µl of IgG 
sepharose for 30 minutes at 4°C. This material was then washed in a column with 100ml 
of Buffer D-Light. After the wash, the material was moved to a microfuge tube and 
placed in 400µl buffer D-Light. Tobacco Etch Virus (TEV) Protease (Dougherty, Cary, 
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and Parks 1989) was used to elute bound material from the column and was incubated for 
1 hour at 19°C.  
2.6.3 Glycerol Gradient Separation 
After the TEV incubation, the sepharose was pelleted and the supernatant was 
removed.  The ~400µl of material was placed on a 10%-30% glycerol gradient (0.5mM 
DTT, 1µM Leupeptin, 1µM Pepstatin, 0.4mM PMSF, 50mM KCl, 20mM HEPES pH8.0, 
1.5mM MgCl2, 0.02% NP-40.) The gradient was run at 51,892 x g for 16 hours / 4°C. 
The gradient was then fractionated by hand from the top in 400µl increments. For Figure 
4.2, these fractions were phenol chloroform extracted, and the aqueous and phenol layers 
separated. The nucleic acids in the aqueous layer were then ethanol precipitated. The 
phenol layer was subjected to the addition of 2.5 volumes of acetone in order to 
precipitate any proteins present (Figure 4.3). 
2.6.4 Calmodulin Purification 
For Section 4.2.6 and 4.2.7, a second affinity step was utilized to minimize 
contaminants. Glycerol gradient fractions 15 through 19 were pooled into a single 2ml 
volume. This volume was then adjusted to a 2mM concentration of CaCl2. 6ml of 
Calmodulin Binding Buffer (0.5mM DTT, 10mM tris-Cl pH8.0, 50mM KCl, 1mM 
magnesium acetate, 1mM imidazole, 2mM CaCl2, 0.1% NP-40, 8% glycerol) was added 
to the gradient material for a total of 8ml. Incubation with 200µl of calmodulin beads 
(Stratagene) followed for a period of 30 minutes at 4°C.  
2.6.5 Post Glycerol Gradient Concentration 
The particle used in section 4.2.5 was concentrated. To create this concentrated 
particle, 1.5 ml of glycerol gradient material (~20% glycerol) was diluted with 4ml of 
Gradient Dilution Solution (Conditions identical to those used in glycerol gradients, but 
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with 5% glycerol) to create a ~10% final glycerol concentration. This 5.5ml of material 
was then placed in an SW-55 and centrifuged for 16 hours at 122,871 x g / 4°C. After 
pelleting the material present, the supernatant was briefly removed from the tube while 
the pellet was resuspended in 100µl of supernatant. This material was then used in 
splicing reactions as indicated below. 
2.6.6 RNA Sample Preparation 
After the addition of a 10% volume of sodium acetate and three volumes of 
ethanol, the RNA samples were stored over night at -30°C. The next morning the tubes 
were spun for 10 minutes at 20,800 xg at 4°C. After 2x washes in 70% DEPC treated 
ethanol, the RNA pellets were placed to dry on the benchtop. Pellets were resuspended in 
10µl DEPC treated H2O. 
2.6.7 Protein Sample Preparation 
Upon addition of 2.5 volumes of acetone to the organic phase of a phenol 
chloroform reaction, the samples were placed at -30°C over night.  A 10 minute, 20,800 
xg spin at 4°C in a microfuge pelleted any proteins. After two washes in 80% ethanol, the 
protein pellets were left to dry on the benchtop. Samples used in protein gels were 
resuspended in protein loading buffer while samples used for mass spectrometry were 
shipped in dry ice as dry pellets. 
2.6.8 Mass Spectrometry 
Mass spectrometric analysis was completed through collaboration with the 
laboratory of John Yates at the Scripps Research Institute, La Jolla California. Briefly, 
after phenol-chloroform separation of proteins the sample was acetone precipitated by 
addition of three volumes ice cold acetone. The sample was then placed at -20°C 
overnight. The next day, the proteins were spun down for 10 minutes at 20,800 x g and 
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washed twice in 80% ethanol. After the final wash was removed, the pellet was left to dry 
on the benchtop. After ~20 minutes the microfuge tube containing the sample was closed 
and shipped over night to the Yates lab on dry ice. 
Upon arrival at the Yates lab, the sample was resuspended in a urea mix to 
denature the proteins (Washburn, Wolters, and J.R. Yates 2001). The sample was then 
reduced (TCEP) and alkylated. After a digest with trypsin and Lys-C, the sample was 
quenched with formic acid and loaded to the mass spectrometric apparatus. The sample 
was then analyzed by Automated Ultra-High-Pressure Multidimensional Protein 
Identification Technology (UHP-MudPIT) (Motoyama, Venable, Ruse, and John R Yates 
2006)(Emily I. Chen, Hewel, Felding-Habermann, and John R. Yates 2006) using a 
ThermoFinnigan LCQ ion source. Spectra were matched to the Saccharomyces Genome 
Database (Eurie L Hong et al. 2008) by the SEQUEST algorithm (Ducret, Van Oostveen, 
Eng, J R Yates, and Aebersold 1998). 
2.6.9 Protein Gels 
Protein samples were run on Invitrogen NuPAGE 4-12% Bis-Tris Gels. Gels were 
then fixed in a 50% methanol / 12% acetic acid solution, washed in double distilled H20, 
and coomassie stained.  
2.6.10 Denaturing RNA Gels 
RNA containing sample was placed on a 20x16x1 mm denaturing polyacrylamide 
gel (7% acrylamide:bisacrylamide [19:1] 8M urea, 1 X TBE) and electrophoresed for 2 
hours at 20 mA.  
2.6.11 Native RNA Gels 
Native RNA samples were loaded onto a 20x16x0.75 mm gel containing 9% 19:1 
acrylamide:bisacrylamide and 1xTBE. The gel was electrophoresed at 25mA for 2.5 
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hours at 4°C. The resulting gel was then transferred to a membrane for Northern blotting 
as described previously. 
2.6.12 Psoralen Crosslinking of RNA 
Glycerol gradient material (400µl) created as described in section 2.6.3 (Figure 
4.2 pooled fractions 15-19) was Psoralen treated using methods described elsewhere 
(Yean and R.J. Lin 1991). Psoralen (Sigma-Aldrich) was added to a final concentration of 
20µg/µl followed by UV (365nm, ~5cm distance from source) exposure on ice for 20 
min. The samples were then phenol-chloroform extracted and precipitated as described in 
the RNA Sample Preparation section. Multiple samples of the RNA were run in multiple 
lanes. This gel was then split prior to membrane transfer, and three different membranes 
were transferred. These membranes were then exclusively probed for U2, U4, or U6. 
2.6.13 RT-PCR 
4µl of purified material from pooled glycerol gradient fractions 15-19 (Figure 4.2) 
was added to 6µl of H2O. This mixture was immediately treated with a 20% volume 
proteinase-K buffer (50mM EDTA pH 8.0, 1% SDS, 1mg/ml proteinase K) for 20 
minutes at 40°C. Next, 200µl of RNA extraction buffer (50mM sodium acetate pH 5.3, 
1mM EDTA, 0.1% SDS, 100 mg/ml  glycogen) was added followed by 200µl of a 
25:24:1 mixture of Phenol (pH 5.3) : Chloroform : isoamyl alcohol. Following two 
phenol chloroform extractions, the sample was chloroform extracted with 200µl 
chloroform. The aqueous layer was then treated with a 10% volume of 3M sodium 
acetate and ethanol precipitated with three volumes of ethanol. Samples were placed at -
30°C over night. After centrifugation for 10 minutes at 20,800 x g the pellets were 
washed 2x with DEPC treated 70% ethanol. Finally, the pellet was left to air dry on the 
benchtop before resuspension in 10µl H2O. 1µl of this suspension was then used in an 
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RT-PCR reaction using the Quagen one step RT-PCR kit following the manufacturer‟s 
instructions. Primer sets against RPS10 (Illustration 2.1), RPS4A, and RPL16A (not 
shown) were used in the RT-PCR reaction. Table 2.3 contains the program parameters 




Illustration 2.1 – RT-PCR primer design 
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Step Temperature (°C) Time 
1 55° 30 minutes 
2 95° 15 minutes 
3 94° 45 seconds 
4 55° 45 seconds 
5 72° 1min 45 seconds 
6 Go to step 3, repeat 31 times 
7 72° 10 minutes 
8 4° Hold 
Table 2.3 – RT-PCR parameters 
  
2.6.14 Extract Preparation for use in Splicing Reactions 
Whole-cell extract for use in splicing reactions was prepared in a manner similar 
to the extract used prior affinity purification. Briefly, the protocol was identical to the 
extract preparation described above, with the sole exception being a final dialysis step in 
Buffer D (20% glycerol, 20 mM HEPES pH 7.9, 0.2 mM EDTA, 50 mM KCl, 0.5 mM 
DTT) as opposed to the earlier Buffer D-Light. After dialysis of the extract, any 
remaining particulate was pelleted by microcentrifugation at 20,817 xg for 10 min at 4°C, 
The extract was then aliquoted, frozen in liquid nitrogen, and stored at -80°C. 
2.6.15 Transcription of Radiolabeled mRNA 
A plasmid was created by combination of the pUC19 vector and the actin gene 
sequence (ACT1). Production of the ACT1 pre-mRNA was placed under the control of the 
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SP6 promoter. In order to prevent run-on transcription, the plasmid was linearized at the 
3‟ end of the coding sequence through use of the EcoRI enzyme (New England Biolabs). 
Following digestion, the DNA was phenol chloroform extracted and ethanol precipitated. 
The transcription reaction itself was set up in the presence of α-P32 labeled GTP. After a 
two hour incubation at 40°C, the reaction was DNase I (1µl) treated for 15 minutes at 
37°C. The reaction was then run on a denaturing RNA gel and the full-length RNA 
transcript was extracted.  
2.6.16 Micrococcal Nuclease Treatment of Extract 
BJ2168 whole cell extract prepared for use in splicing reactions was treated with 
micrococcal nuclease as described by Yean and Lin (Yean and R.J. Lin 1991). 1 µl of 
20mM CaCl2 was added to 15 µl of extract on ice. Finally, 4µl of micrococcal nuclease 
(Sigma 22 U/µl ) was added and the reaction was incubated for 30 minutes at 30°C. The 
nuclease was quenched with the addition of 2 µl of 50mM EGTA and placed on ice until 
use.  
2.6.17 Splicing Reactions 
Splicing reactions were carried out as described previously (R.J. Lin, Newman, 
S.C. Cheng, and J. Abelson 1985) using either whole cell extract or extract that was 
micrococcal nuclease treated prior to use. Reactions were assembled on ice under the 
following buffer conditions: 60mM potassium phosphate pH 7.0, 2mM ATP, pH 7.0, 
3.2mM MgCl2, 3% PEG-8000, 1mM spermidine. In addition to these additives, the 10µl 
reactions contained 1µl of radiolabeled pre-mRNA (~1,000 cpm/µl) and 4µl of either 
regular or micrococcal nuclease treated BJ2168 whole cell extract. Reactions were 
incubated at 22°C for 30 minutes. The reaction was then treated with a 2µl Proteinase-K 
buffer (50mM EDTA pH 8.0, 1% SDS, 1mg/ml Proteinase K) for 20 minutes at 40°C. 
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Next, 200 µl of RNA extraction buffer (50mM sodium acetate pH 5.3, 1mM EDTA, 0.1% 
SDS, 100 mg/ml glycogen) was added followed by 200 µl of a 25:24:1 mixture of phenol 
(pH 5.3) : chloroform : isoamyl alcohol. After a single repetition of the extraction, a 10% 
volume of 3M sodium acetate was added to the aqueous layer. The addition of three 
volumes of ethanol precipitated any nucleic acids present. Samples were placed at -30°C 
over night. After centrifugation for 10 minutes at 20,800 xg, the pellets were washed with 
DEPC treated 70% ethanol. The pellet was resuspended in denaturing loading buffer and 
run on a 20x16x1mm denaturing gel (7% 29:1 acrylamide: bisacrylamide, 7M Urea, 1X 
TBE) for 2 hours at 15mA. The gel was then dried and imaged in a phosphorimager (GE 
Healthcare Typhoon).  
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The pre-mRNA splicing machinery requires rearrangement of multiple RNA and 
protein components prior to, during and after addressing the pre-mRNA substrate (J.P. 
Staley and C. Guthrie 1998)(Madhani and C. Guthrie 1994)(M.J. Moore, Query, and P.A. 
Sharp 1993). After the initial recognition of the 5‟ splice site by the U1 snRNP (Ruby and 
J. Abelson 1988)(B. Seraphin, Kretzner, and Rosbash 1988)(Siliciano and C. Guthrie 
1988), the pre-mRNA branch point sequence interacts via RNA-RNA and RNA-protein 
contacts with the U2 snRNP in the first energy dependent step of the splicing reaction (J. 
Wu and Manley 1989)(Parker, Siliciano, and C. Guthrie 1987). This process is followed 
by the functional engagement of a pre-assembled U4/U6•U5 snRNP (M.M. Konarska and 
P.A. Sharp 1987)(S.C. Cheng and J. Abelson 1987). A number of structural 
rearrangements leading to formation of the activated spliceosome then occur. In the 
process, an intermolecular helix formed between U4 and U6 snRNAs is unwound by 
Brr2p, allowing the formation of a U2/U6 base-pairing interaction required for splicing 
(Raghunathan and C. Guthrie 1998b)(Hausner, Giglio, and Weiner 1990)(D.A. 
Wassarman and J.A. Steitz 1993)(Madhani and C. Guthrie 1992). After the catalytic steps 
of pre-mRNA splicing are completed, spliceosome disassembly liberates the remaining 
U2, U5 and U6 snRNPs from the lariat intron RNA (Martin, S. Schneider, and Schwer 
2002)(Small, Leggett, Winans, and Jonathan P Staley 2006). U6 snRNP then base-pairs 
with U4 to form the U4/U6 di-snRNP (Raghunathan and C. Guthrie 1998a) which 
associates with the U5 mono snRNP to reform the U4/U6•U5 snRNP. 
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Many protein-protein interactions within the U4/U6•U5 snRNP have been 
previously described. Among the most well-studied interactions are between the U5 
snRNP components Brr2p/[U5-200K], Prp8p/[U5-220K], and Snu114p/[U5-116K] (T. 
Achsel, Ahrens, Brahms, Teigelkamp, and R. Lührmann 1998). Other players in 
U4/U6•U5 snRNP formation include Prp6p/[U5-102K] a tetratricopeptide repeat (TPR) 
protein which is known to interact with the U5 proteins Snu40p/[U5-52K] (Laggerbauer 
et al. 2005), Dib1p/[U5-15K] (Uetz et al. 2000), Brr2p,Snu114p and Prp8p (S.B. Liu, 
Rauhut, H.P. Vornlocher, and R. Lührmann 2006) and the U4/U6•U5 snRNP-specific 
Snu66p/[U4/U6•U5-110K] (S.B. Liu, Rauhut, H.P. Vornlocher, and R. Lührmann 
2006)(van Nues and Jean D. Beggs 2001). Additional interactions have been 
characterized between Prp6p and the U4/U6 components Prp3p/[U4/U6-90K] and 
Prp31p/[U4/U6-61K] (S.B. Liu, Rauhut, H.P. Vornlocher, and R. Lührmann 2006). 
Analysis of a prp6 mutant revealed that U4/U6•U5 snRNP formation is disturbed 
(Galisson and Legrain 1993). While yeast Prp6p is accepted to be stable components of 
the U4/U6•U5 snRNP, Prp6p has been previously characterized as a U4/U6 component 
(Abovich, Legrain, and Rosbash 1990) whereas the U5-102K protein is a stable 
component of the human U5 snRNP. These data have led to a model in which Prp6p acts 
as a bridging factor between the U5 snRNP and U4/U6 snRNP during the formation of 
the U4/U6•U5 snRNP, but the details of assembly have not been well characterized.  
Among the partners known to interact with Prp6p are Snu40p and Snu66p; 
Snu40p is exclusively associated with the U5 snRNP in Saccharomyces cerevisiae (S. W. 
Stevens et al. 2001) while Snu66p is exclusively associated with the U4/U6•U5 snRNP 
(Scott W. Stevens and John Abelson 1999)(A. Gottschalk et al. 1999). The mammalian 
orthologs of Snu40p and Snu66p, U5-52K and U4/U6•U5-110K, are likewise found 
exclusively in the U5 and U4/U6•U5 snRNP respectively (Laggerbauer et al. 2005). 
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The GYF domain of U5-52K is thought to be responsible for protein-protein 
interactions (Freund, Dötsch, Nishizawa, Reinherz, and G Wagner 1999) and it has been 
crystallized in complex with one of its binding partners, U5-15K (Nielsen, Sunbin Liu, 
Reinhard Lührmann, and Ficner 2007). Deletion of SNU40 results in no observable 
growth phenotype (S. W. Stevens et al. 2001) yet the yeast SNU66 deletion mutant 
displays a slight cold sensitive growth phenotype and a splicing defect at reduced 
temperatures (S. W. Stevens et al. 2001). 
We have determined that removal of SNU40 from Δsnu66 strains resulted in 
synthetic lethality at reduced temperatures. In Δsnu66 strains, U4/U6•U5 snRNP 
formation is inhibited, and at reduced temperatures, the U4/U6•U5 snRNP that has 
formed is defective for U4/U6 unwinding by Brr2p. In the Δsnu40/Δsnu66 strain, the 
U4/U6•U5 snRNP biogenesis defect at reduced temperatures is bypassed, however the 
U4/U6•U5 snRNP remains defective in U4/U6 unwinding. Intriguingly, a transient Prp6p 
intermediate with U5 snRNP is reduced in Δsnu40, and increased in Δsnu66. We present 
a model in which U4/U6•U5 snRNP assembly proceeds through a series of events 
including serial interaction of Prp6p with Snu40p and Snu66p. Under unfavorable growth 
conditions, these non-essential proteins are required for biogenesis events to promote the 




3.2.1 Δsnu40 / Δsnu66 Strains are Synthetically Lethal at 16°C 
Previous work has shown that Δsnu66 cells are cold sensitive. We constructed 
isogenic Saccharomyces cerevisiae strains lacking SNU40, SNU66, or both. Serial 
dilutions of the strains show no growth phenotype for any deletion at 31°C, and the 
Δsnu40 strain was slightly temperature sensitive at 37°C (Figure 3.1). Subsequent 
removal of SNU40 from Δsnu66 resulted in synthetic lethality at 16°C (Figure 3.1) 






Figure 3.1 – Δsnu4+Δsnu66 strains are synthetically lethal at 16°C  
The cold sensitive Δsnu66 strain is lethal at 16°C upon subsequent deletion of 
SNU40. Isogenic SNU40/SNU66, Δsnu40, Δsnu66, Δsnu40/Δsnu66 strains were grown in 
YPD at 31°C, serially diluted and plated on SC media. Identically prepared plates were 




3.2.2 U4/U6 and U4/U6•U5 levels in Mutant Strains  
Whole-cell splicing extract from Δsnu40, Δsnu66, and Δsnu40/Δsnu66 and the 
isogenic wild type (WT) strain were generated and electrophoresed through a native gel 
designed to resolve the U4/U6•U5 snRNP from U4/U6 and U6 snRNPs (Raghunathan 
and C. Guthrie 1998a). Gels were transferred to membranes and northern blotted to detect 
the U6 snRNA. At 31°C, U4/U6•U5 snRNP levels were reduced in the Δsnu66 strains 
(Figure 3.2 lane 3) which was exacerbated in strains grown at 19°C (Figure 3.2 lane 7). 
The reduction in U4/U6•U5 snRNP levels at 19°C in Δsnu66 was accompanied by an 
increase in U4/U6 indicating the defect was not in overall reduction in snRNP levels, but 
the inability to assemble U4/U6•U5 snRNP from U5 and U4/U6 snRNPs. The Δsnu40 
extracts do not show defects in snRNP assembly at either temperature (Figure 3.2 lanes 2, 
6). Remarkably, in Δsnu40/Δsnu66 extracts the U4/U6•U5 snRNP assembly defect seen 
in Δsnu66 extracts is bypassed by removal of SNU40 (Figure 3.2 lanes 3, 4; 7, 8). We 
also note that the migration of the U4/U6 snRNP is slower in all strains lacking Snu40p 
(Figure 3.2 lanes 2, 4, 6, 8). 
3.2.3 Reduced ATP-dependent U4/U6•U5 snRNP Dissociation 
Whole-cell splicing extracts were supplemented with ATP to stimulate Brr2p-
dependent unwinding of the U4/U6 snRNAs leading to U4/U6•U5 snRNP dissociation 
(Raghunathan and C. Guthrie 1998b)(S. W. Stevens et al. 2001). In the WT strain at 
31°C, this resulted in reduced U4/U6•U5 levels (Figure 3.2 and Figure 3.3 lanes 1, 5, 9, 
13) and increased levels of a U6 RNP lacking Prp24p, termed U6* (Raghunathan and C. 
Guthrie 1998b). The snRNP distribution in Δsnu40 extracts, at both 31°C and 19°C in the 
 63 
presence of ATP was indistinguishable from WT (Figure 3.3 lanes 10, 14). At 31°C in 
the Δsnu66 strain, there is some dissociation of the U4/U6•U5 snRNP upon ATP 
treatment (Figure 3.2 lane 3, Figure 3.3 lane 11) but no dissociation at 19°C (Figure 3.2 
lane 7, Figure 3.3 lane 15). In the Δsnu40/Δsnu66 strain, a slight ATP-dependent 
disruption of the U4/U6•U5 snRNP was noted (Figure 3.2 lane 4, Figure 3.3 lane 12), 
however there is no disruption of U4/U6•U5 snRNP by ATP at 19°C (Figure 3.2 lane 8, 
Figure 3.3 Lane 16). We also note in the Δsnu40/Δsnu66 extract, an additional U6 snRNP 





Figure 3.2 - U4/U6•U5 snRNP formation and dissociation in mutant strains 
U4/U6•U5 snRNP formation is defective upon removal of SNU66 and restored 
upon subsequent removal of SNU40. Cells were grown at 31°C and maintained at 31°C 
or shifted to 19°C until OD (A600) ~ 1.5. Splicing extracts were prepared and incubated 
at the indicated temperatures prior to electrophoretic separation on native polyacrylamide 




Figure 3.3 - U4/U6•U5 snRNP formation and dissociation in mutant strains  
U4/U6•U5 snRNP formation is defective upon removal of SNU66 and restored 
upon subsequent removal of SNU40. Cells were grown at 31°C and maintained at 31°C 
or shifted to 19°C until OD (A600) ~ 1.5. Splicing extracts were prepared and incubated 
at the indicated temperatures prior to electrophoretic separation on native polyacrylamide 
gels. ATP was added to a final concentration of 2mM to dissociate U4/U6•U5. U4/U6, 
U6, U6* and spliceosome complexes are indicated. 
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3.2.4 GTP does not bypass the U4/U6•U5 Disruption Defect 
Staley and colleagues have shown that the guanosine nucleotide binding by 
Snu114p regulates several RNA helicase-dependent steps in splicing (Small, Leggett, 
Winans, and Jonathan P Staley 2006). We tested whether addition of GTP to the ATP 
reactions bypassed the ATP resistance and increased U4/U6•U5 snRNP dissociation in 
Δsnu66 strains. In WT extract,U4/U6•U5 snRNP dissociation was seen upon ATP + GTP 
treatment, as expected (Figure 3.4 lanes 1-3). While the Δsnu40 extracts exhibit behavior 
similar to WT (Figure 3.4 lanes 4-6), U4/U6•U5 snRNP in Δsnu66 extracts (Figure 3.4 
lanes 7-9) and the Δsnu40/Δsnu66 extracts (Figure 3.4 lanes 10-12) remains resistant to 




Figure 3.4 – GTP does not enhance the ATP dependent disassociation 
Addition of GTP does not enhance the ATP dependent dissociation of U4/U6•U5 
snRNP in Δsnu66 or Δsnu40/Δsnu66 extracts. Temperature shifted (19°C) extracts were 
prepared as in Figures 3.3 and 3.4 but supplemented without nucleotide, with ATP or 
with ATP + GTP. (All ATP and GTP additions resulted in a 2mM final concentration.)
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3.2.5 Removal of SNU66 Decreases U4/U6 unwinding 
Disruption of WT U4/U6•U5 snRNP upon ATP addition results from unwinding 
U4/U6 base-pairing, and likely, disruption of protein-protein interactions. To determine 
whether the U4/U6•U5 snRNP in Δsnu66 and Δsnu40/Δsnu66 extracts was incapable of 
U4/U6 unwinding or if U4/U6 was unwound but remained associated due to 
inappropriate protein-protein interactions in the mutants, we performed a U4/U6 
unwinding assay (Raghunathan and C. Guthrie 1998b). The WT, Δsnu40, Δsnu66 and 
Δsnu40/Δsnu66 strains were modified to contain a TAP tag (Puig et al. 2001) on the U5 
component Brr2p. Brr2p-containing material was affinity captured, washed and incubated 
in buffer containing 2 mM ATP. Denaturing northern blot analysis of the supernatant and 
snRNAs remaining on the beads shows that in the WT extract, ATP drives efficient 
U4/U6 unwinding and release (Figure 3.5 lanes 1-3). The efficiency of this activity is 
unaffected in Δsnu40 extracts (Figure 3.5 lanes 6-8). In Δsnu66 extracts, however, 
decreased unwinding of U4 and U6 was seen (Figure 3 lanes 11-13). The Δsnu40/Δsnu66 
mutant strain similarly exhibited decreased U4/U6 unwinding efficiency (Figure 3, lanes 
16-18). Similar to that shown in Figure 2B, treatment of the Brr2p-containing material 
with ATP + GTP did not enhance the ability to unwind U4/U6 in the complexes (Figure 





Figure 3.5 – U4/U6 duplex unwinding 
U4/U6 duplex unwinding is deficient in Δsnu66 and Δsnu40/Δsnu66 extracts. 
Brr2p-TAP containing snRNPs were captured on IgG sepharose, washed and incubated 
with buffer containing ATP or ATP + GTP. Extracted nucleic acids from total Brr2p-
TAP snRNP (E), ATP-treated supernatant (S) or beads after ATP treatment and washing 
(B) were separated on denaturing RNA gels, transferred to nylon membranes and 




3.2.6 Aberrant Complexes in Δsnu66 and Δsnu40/Δsnu66 
The WT and deletion strains were modified with a TAP tag on Prp6p. Extracts 
from each of these strains, and the Brr2p-TAP strains, were analyzed by native gel 
analysis and western blotting for the TAP tag (Figure 3.6). Remarkably, WT cells grown 
at 31°C and extract incubation at 31°C shows very little Prp6p in U4/U6•U5 snRNP 
(Figure 3.6A lane 1). In each of the mutant strains, there is very little to no Prp6p 
detected in a U4/U6•U5 snRNP-sized band in extracts prepared from cells grown at 31°C 
(Figure 3.6A lanes 2-4). Prp6p is seen stably associated with the U4/U6•U5 snRNP in 
cells shifted to 19°C prior to extract preparation and subsequent incubation at 19°C 
(Figure 3.6A lanes 5-8) indicating a stabilization of Prp6p at lower temperatures.  
Interestingly, in Δsnu66 cells, much of the Prp6p signal resides in a spliceosome-
sized band (Raghunathan and C. Guthrie 1998a) in the 31°C samples, and in an 
aberrantly migrating U4/U6•U5 snRNP-like band (U4/U6•U5 snRNP*) in the 19°C 
samples (Figure 3.6A lanes 7,8). Treatment of identical extract samples with 2 mM ATP 
does not dissociate the spliceosome-sized bands, nor the U4/U6•U5 snRNP* species in 
Δsnu66 extracts (data not shown). These results were confirmed using the U4/U6•U5 
snRNP-associated Brr2p as well (Figure 3.6B) although unlike Prp6p, Brr2p is a stable 
component of the U4/U6•U5 snRNP at 31°C. These data indicate that in Δsnu66 and 
Δsnu40/Δsnu66 cells, the most snRNP-associated Prp6p and Brr2p are found in an 
aberrantly migrating complex or locked in the spliceosome, however the migration of 
U4/U6•U5 snRNP* is not detectably different from the migration of U4/U6•U5 snRNP in 
glycerol gradients (see below). This is true at both permissive and non-permissive 
temperatures in Δsnu66 and Δsnu40/Δsnu66 extracts, although the effect is more severe at 
low temperatures.  
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Figure 3.6 - Prp6p and Brr2p are contained in larger complexes  
A. Prp6p-TAP extracts with the indicated SNU40 and SNU66 genotypes were 
separated in non-denaturing polyacrylamide gels, transferred to nitrocellulose membranes 
and western blotted with PAP. Spliceosome and U4/U6•U5 complexes and the predicted 
positions of the U4/U6 and U6 snRNPs are indicated.  
B. Brr2-TAP extracts with the indicated SNU40 and SNU66 genotypes were 
analyzed as described in [A].
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3.2.7 Transient Association of Prp6p with U5 snRNP 
Although Prp6p is not a stable, stoichiometric component of the U5 snRNP in 
yeast (S. W. Stevens et al. 2001), we hypothesized that if there was collaboration between 
Snu40p and Snu66p in U4/U6•U5 snRNP assembly, that there may be a transient 
intermediate in which Prp6p is found with some fraction of the U5 snRNP. To determine 
whether this was the case, and to determine how the Δsnu40 and Δsnu66 deletions might 
affect this interaction, we purified the Prp6p-containing material by TAP affinity 
purification from WT, Δsnu40 and Δsnu66 strains. TEV protease-eluted material was 
sedimented through a glycerol velocity gradient and the snRNAs in the fractions were 
detected by northern blotting in from denaturing PAGE gels (Figure 3.7). When 
performing similar experiments with Brr2p, the U5 to U4/U6•U5 snRNP ratio is typically 
1:1 ((S. W. Stevens et al. 2001); SWS unpublished data), however the ratio of U5 to 
U4/U6•U5 snRNP in the Prp6p-containing material from the WT strain was very low as 
determined by phosphorimage quantitation (1:19) (Figure 3.7A). In Δsnu40 extracts, the 
proportion was reduced by more than half (1:43) indicating a diminished interaction of 
Prp6p with the U5 snRNP in the absence of Snu40p (Figure 3.7B). In Δsnu66 extracts, 
the proportion of Prp6p-associated U5 to U4/U6•U5 snRNP was increased by more than 
2 fold (1:9) suggesting that the transient Prp6p-U5 association was stronger, or lasted 





Figure 3.7 – Prp6-TAP immunoprecipitates U5 snRNP 
A small portion of the U5 mono-snRNP is affinity-purified using Prp6-TAP. 
Prp6-TAP affinity-purified material (TEV eluate) was layered onto glycerol velocity 
gradients. Gradients were fractionated and nucleic acids and proteins were separated by 
organic extraction. RNA was separated on a urea-PAGE gel. Nucleic acids were 
transferred to nylon membranes and hybridized with radiolabeled oligonucleotides to 
detect U4, U5 and U6 snRNAs. Samples from isogenic SNU40/SNU66 [A], Δsnu40 [B], 




3.2.8 Temperature Dependent Prp6p Stability in snRNP Complexes 
Previous studies of have shown that U4/U6•U5 snRNP in yeast and humans 
contains Prp6p (S. W. Stevens et al. 2001)(Scott W. Stevens and John Abelson 1999)(A. 
Gottschalk et al. 1999)(Behrens and R. Lührmann 1991). We note that in WT extracts 
incubated at 31°C, Prp6p becomes de-stabilized from the U4/U6•U5 snRNP, and that 
incubation at 19°C stabilized Prp6p association with U4/U6•U5 snRNP (Figure 3.6 lanes 
1,5). Although previous studies have shown the human (Evgeny M. Makarov, Olga V. 
Makarova, Tilmann Achsel, and Reinhard Luhrmann 2000) and yeast (Abovich, Legrain, 
and Rosbash 1990) orthologs of Prp6p are present in the U5 and U4/U6 snRNPs 
respectively, our data are in conflict as there is no Prp6p-TAP signal in a U4/U6-sized 
complex in any strain at either temperature in the native gels (Figure 3.6A) nor was it a 
stoichiometric component in the stable U5 snRNP from yeast (S. W. Stevens et al. 2001). 
Examining the association of the TAP-tagged Prp6p at 19°C via native gel showed Prp6p 
to be stably associated with the U4/U6•U5 snRNP as well as spliceosome in WT and 
Δsnu40 strains. To address the association of Prp6p with different complexes in these 
extracts in a manner not dependent on native gel electrophoresis, we sedimented whole-
cell extracts through glycerol gradients to separate free Prp6p from complexes (Figure 
3.8). In WT, Δsnu40 and Δsnu66 extracts, Prp6p was primarily associated with 
U4/U6•U5 snRNP-sized complexes, but to a lesser extent, trailing off into upper fractions 
(Figure 3.8A, 3.8B, 3.8C). Whether this trailing effect is due to association of Prp6p with 
different complexes or dissociation during the gradient analysis is difficult to determine, 
but the latter is more likely given the results presented in Figure 3.6A. In the 
Δsnu40/Δsnu66 extracts, however, Prp6p was found throughout the gradient indicating a 
significant destabilization from splicing complexes (Figure 3.8D). 
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Figure 3.8 – Prp6p is destabilized in a ΔSNU40+ΔSNU66 mutant 
Extract separated on a gradient from Prp6p-TAP tagged strains. [A] contains both 





Details involving how cells assemble and maintain proper levels of the 
spliceosomal snRNPs remain largely unknown. Additionally, the presence of myriad 
forms of some snRNPs (such as U5;((S. W. Stevens et al. 2001)(Scott W. Stevens and 
John Abelson 1999)(A. Gottschalk et al. 1999)(Behrens and R. Lührmann 1991)(O.V. 
Makarova, E.M. Makarov, H. Urlaub, C.L. Will, Gentzel, Wilm, and R. Lührmann 
2004)(A. Gottschalk, B. Kastner, R. Luhrmann, and P. Fabrizio 2001)(Bach, 
Winkelmann, and R. Lührmann 1989))) raises several questions as to how eukaryotic 
cells functionally discriminate between them and properly maintain directionality in their 
formation and usage. In WT cells, Snu40p is found in the U5 snRNP but not the 
U4/U6•U5 snRNP and Snu66p is found only in the U4/U6•U5 snRNP. Both Snu40p and 
Snu66p have demonstrated interactions with Prp6p. Here we have characterized the role 
of Snu40p and Snu66p in U4/U6•U5 snRNP formation and function and the relevance of 
their interactions with Prp6p. 
While deletion of SNU40 does not result in a U4/U6•U5 snRNP assembly defect, 
the deletion of SNU66 does block formation of this particle at low temperatures (Figure 
2A). The Δsnu66 strain accumulates the U4/U6 particle under these conditions indicating 
a defect in U4/U6•U5 snRNP assembly. This is in contrast to the human ortholog which 
can be immunodepleted from salt-treated extracts with little effect on U4/U6•U5 snRNP 
assembly (O.V. Makarova, E.M. Makarov, and R. Lührmann 2001). 
The association of Prp6p prior to entry into the yeast U4/U6•U5 snRNP has been 
a subject of some debate, with previous data including it in the U4/U6 snRNP (Abovich, 
Legrain, and Rosbash 1990) while data regarding the human protein places it in the U5 
snRNP (Evgeny M. Makarov, Olga V. Makarova, Tilmann Achsel, and Reinhard 
 77 
Luhrmann 2000). Our data indicate that Prp6p is only a stable binding partner in the 
U4/U6•U5 snRNP and larger complexes (Figure 3.6A), however it can be seen as a 
transient interacting partner with a small portion of U5 snRNP (Figure 3.7). An 
explanation for this discrepancy is that Prp6p-associated yeast U4/U6•U5 snRNP was 
dissociated at the elevated salt levels used which left Prp6p with the U4/U6 portion of the 
disassembled U4/U6•U5 snRNP, while the human homologue has a stronger association 
with the U5 components. Nonetheless, given our data and the mammalian interaction data 
between Snu40p and Prp6p orthologs (Laggerbauer et al. 2005), yeast Prp6p forms a 
transient intermediate with the U5 snRNP through its interaction with Snu40p prior to 
U4/U6•U5 snRNP formation. 
Based on the previously characterized interactions and data presented here, we 
propose a model for the functions of Snu40p, Snu66p, and Prp6p in U4/U6•U5 snRNP 
assembly (Illustrations 3.1-3.4). In WT cells, Prp6p interacts transiently with Snu40p in 
the U5 snRNP. As the U4/U6 snRNP joins the U5 snRNP to create the U4/U6•U5 
snRNP, Prp6p is handed off to the U4/U6•U5 snRNP specific Snu66p with concomitant 
Snu40p release (Illustration 3.4). In the Δsnu40 strain,Prp6p is able to properly load into 
the U4/U6•U5 snRNP via its interaction with Snu66p ((S.B. Liu, Rauhut, H.P. 
Vornlocher, and R. Lührmann 2006); Illustration 3.1). In the Δsnu66 strain, the process 
proves to be more problematic, as Snu40p and Prp6p remain intertwined. This interaction 
blocks U4/U6•U5 snRNP formation and leads to increased U4/U6 snRNP levels as well 
as a >2-fold enrichment of Prp6p-associated U5 intermediate (Illustration 3.2). 
Furthermore, the U4/U6•U5 snRNP that forms in these circumstances is deficient in 
Brr2p unwinding activity, likely due to some regulatory function of Snu66p upon Brr2p 
(S.B. Liu, Rauhut, H.P. Vornlocher, and R. Lührmann 2006)(van Nues and Jean D. 
Beggs 2001). The Δsnu66 U4/U6•U5 snRNP formation block is relieved by subsequent 
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deletion of SNU40 (Illustration 3.3), indicating that these proteins serve to function via a 
common interacting partner, Prp6p. Despite efficient U4/U6•U5 snRNP formation at 
permissive temperatures, the Δsnu40/Δsnu66 strain is dead at 16°C (Figure 3.1). The 
cold-sensitive phenotype is likely the result of a U4/U6•U5 snRNP particle that is unable 
to efficiently unwind U4 and U6 snRNAs. Analysis of Brr2p unwinding activity (Figure 
3.5) confirms the reduced unwinding activity of Brr2p in the Δsnu66 strain as well as the 
double deletion strain. Furthermore, added ATP (Figure 3.5 lanes 18-19) or ATP and 
GTP (Figure 3.5 lanes 19-20) in Δsnu40/Δsnu66 extracts does not dissociate U4/U6•U5 
snRNP levels relative to the non-ATP supplemented extract. The reduced U4/U6 
unwinding activity should inevitably lead to a buildup of the spliceosome just prior to 
activation, likely at the A2-1 step (S.C. Cheng and J. Abelson 1987). Indeed, increased 
spliceosome levels are seen in strains lacking Snu66p (Figure 3.2, Figure 3.6A). 
An additional mechanism by which the A2-1 complex may stall is through 
malformation of the spliceosome due to a misplaced or unstable Prp6p. Assuming that the 
purpose of Snu40p and Snu66p are to ensure proper loading of Prp6p into the U4/U6•U5 
snRNP, it follows that deletion of these chaperones results in instability and likely, 
malfunction under non-optimal conditions. The behavior of Prp6p in a glycerol gradient 
(Figure 3.8D) confirms that it is most destabilized from the U4/U6•U5 snRNP in 
Δsnu40/Δsnu66 extract. It is likely these additive effects are responsible for elevated 
levels of spliceosomal complexes in the double deletion in comparison to the Δsnu66 
strain (Figure 3.6A lanes 7, 8). Others have noted that non-essential gene products 
functioning in essential cellular processes often have regulatory roles which only affect 
cell function or cell growth under certain conditions (Fang, Rocha, and Danchin 2005). 
Snu40p and Snu66p appear to be functioning in a similar manner in spliceosome 
assembly. Their regulation of U4/U6•U5 snRNP assembly is not essential in rich medium 
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at optimal growth temperatures. However when cells are stressed by decreasing the 
growth temperature, the optimal assembly of the U4/U6•U5 snRNP is disrupted in the 
















Illustration 3.3 – Prp6p is destabilized from tri-snRNP in ΔSNU40 + ΔSNU66 mutants 
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Illustration 3.4 – A model for tri-snRNP formation 
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Keeping this new model of tri-snRNP formation in mind it is informative to 
revisit the previously published two hybrid and biochemical interaction data that was 
presented in the first chapter. Illustration 3.5 arranges this data with this new structure in 





Illustration 3.5 – Revisited protein-protein interactions leading to the tri-snRNP 
Saccharomyces cerevisiae tri-snRNP interactions are combined with data from 
their human homologs (subtitled in parenthesis). Dashed lines indicate yeast two-hybrid 
interactions, while solid lines indicate co-immunopurification data. Proteins in blue are 
found in both U5 as well as the tri-snRNP. Snu40p, in white, is U5 specific. Proteins 
found in both U4/U6 and tri-snRNP are colored yellow. Snu66p, in green, is tri-snRNP 
specific. Lastly, Prp6p/102k is found in tri-snRNP in both species but has been reported 
to be a U5 specific protein in humans. Note that this figure represents protein interactions 
only. Snu40p and Snu66p are never simultaneously located in the same particle. Figure 
based on data from (van Nues and Jean D. Beggs 2001)(Olga V Makarova, Evgeny M 
Makarov, Sunbin Liu, Hans-Peter Vornlocher, and Reinhard Lührmann 2002)(S.B. Liu, 
Rauhut, H.P. Vornlocher, and R. Lührmann 2006)(Gonzalez-Santos et al. 2002).. 
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CHAPTER 4:  PURIFICATION OF A FUNCTIONAL PRE-
CATALYTIC SPLICEOSOME 
4.1 INTRODUCTION 
In the process of spliceosome assembly and activation several rearrangements 
occur, largely by the action of RNA helicases (Tanner and P. Linder 2001). While this 
process was explored in depth in the first chapter, a brief review follows. The process 
(Illustration 4.1) begins with the base pairing of the U1 snRNA to the 5‟ splice site 
forming the commitment complex (Krainer 1997). Following this event, branchpoint 
binding proteins engage their target (Rutz and B. Seraphin 1999) with the U2 snRNP 
soon following. At this point, the B-complex or Pre-Spliceosome is formed (S.C. Cheng 
and J. Abelson 1987). The addition of a preformed tri-snRNP and other protein factors 
create the precatalytic spliceosome (A2-1 complex) (S.C. Cheng and J. Abelson 1987). 
After a series of ATP-driven base pairing rearrangements, the U1 and U4 snRNPs are 
released and the activated spliceosome (A1 complex) is formed. These steps see the 
Prp28p dependent unwinding of U1 from the 5‟ splice site (J P Staley and C Guthrie 
1999) as well as the Brr2p driven unwinding of U4 from U6 (Xu, Nouraini, Field, Tang, 
and Friesen 1996)(Lauber et al. 1996)(D. H. Kim and Rossi 1999). These actions free 
both the intron of 5‟ splice site and U6 snRNA for future base pairing. At this time the 
U5 snRNA concurrently addresses the exon at the 5‟ splice site. The completion of these 
events result in the formation of the A1 complex of the spliceosome. The next 
rearrangement of the spliceosome results from the actions of Prp2p, which moves the 
branchpoint adenosine into close proximity of the 5‟ splice site (Silverman et al. 2004). 
The steps that follow complete the splicing cycle through two transesterification 





Illustration 4.1 - Rearrangements prior to the 1
st
 catalytic step of splicing 
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4.1.1 Formation of the Activated Spliceosome  
The reductionist approach used in the past has resulted in a modest understanding of the 
composition and movements of the component snRNPs that comprise the spliceosome. 
Complexes like the U4/U6 di-snRNP and the U4/U6∙U5 tri-snRNP are relatively well 
characterized (Nottrott, H. Urlaub, and R. Lührmann 2002)(Raghunathan and C. Guthrie 
1998a)(Scott W. Stevens and John Abelson 1999)(S. W. Stevens et al. 2001). 
Nevertheless, much remains unknown about the larger spliceosome complexes like the 
fully assembled, precatalytic A2-1 complex. In addition to the substrate pre-mRNA, this 
complex contains all five snRNAs (S.C. Cheng and J. Abelson 1987). Like the B 
complex before it, A2-1 includes a pre-mRNA that is base paired with U1 at the 5‟ splice 
site while U2 remains base paired at the branchpoint sequence. The addition of tri-snRNP 
to the complex sets in motion the process that leads to the activated spliceosome. 
Namely, the U6 snRNA must basepair with both the 5‟ splice site as well as the U2 
snRNA (D.A. Wassarman and J.A. Steitz 1993). Additionally, the Lsm protein ring must 
be removed from U6 (Chan, Der-I Kao, Wei-Yu Tsai, and Soo-Chen Cheng 2003). This 
requires not only the Prp28p-dependant release of the U1 snRNA from its position on the 
mRNA (J P Staley and C Guthrie 1999), but also the unwinding of the previous U4/U6 
snRNA pairing. Brr2p, in concert with Snu114p, is responsible for the unwinding of this 
extensively basepaired U4/U6 duplex (Raghunathan and C. Guthrie 1998b)(Small, 
Leggett, Winans, and Jonathan P Staley 2006). Once free of U4, U6 is then able to base-
pair with the substrate while U4 is released from the spliceosome and fed into a snRNP 
recycling pathway. After U6 is base-paired with the 5‟ splice site, the remodeling 
continues via addition of a number of protein factors termed the Nineteen Complex 
(NTC) (Chan and Soo-Chen Cheng 2005). 
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Prp19p is known to be associated with seven other proteins (Cef1p, Isy1p, 
Ntc20p, Snt309p, Syf1p, Syf2p, Syf3p) to form the NTC (S.C. Cheng, W.Y. Tarn, T.Y. 
Tsao, and J. Abelson 1993)(W.Y. Tsai et al. 1999)(W.Y. Tarn, Hsu, K.T. Huang, H.R. 
Chen, H.Y. Kao, K.R. Lee, and S.C. Cheng 1994)(Hau-Ren Chen, Shr-Peng Jan, Twee 
Y. Tsao, Sheu, Josette Banroques, and Soo-Chen Cheng 1998)(C.H. Chen, W.Y. Tsai, 
H.R. Chen, C.H. Wang, and S.C. Cheng 2001)(Chun-Hong Chen et al. 2002). It has been 
reported that the NTC is not found in the pre-spliceosome (W.Y. Tarn, K.R. Lee, and 
S.C. Cheng 1993). Nevertheless, the complex plays a pivotal role in the adaptation of U6 
during the transition to the active complex (Chan and Soo-Chen Cheng 2005). Within 
these parameters, the exact sequence of NTC arrival to the spliceosome remains a matter 
of debate. Even beyond this, however, the presence of the NTC in splicing complexes 
represents a broader debate between the stepwise model of assembly and the penta-
snRNP. The previous characterization of the penta-snRNP complex found all eight core 
NTC components to be present (Scott W. Stevens et al. 2002). This data may indicate that 
it is the true functional, on pathway intermediate. Thus, under the preformed spliceosome 
hypothesis, in vitro purifications using harsh salt conditions have been characterizing a 
subset of the factors in the in vivo pre-A2-1 complex. Therefore, omission of the NTC 
from these datasets may be biochemical artifact. 
What is known about the NTC is that it is required for stable association of U5 
and U6 with the spliceosome after the exit of U1 and U4 (Chan, Der-I Kao, Wei-Yu Tsai, 
and Soo-Chen Cheng 2003). This stabilization is concurrent with a shift in U6 
basepairing and release of the Lsm protein ring (Chan, Der-I Kao, Wei-Yu Tsai, and Soo-
Chen Cheng 2003). The next step in the process is a Prp2p-dependent rearrangement of 
the spliceosome in preparation the for the first transesterification reaction (J.H. Chen and 
R.J. Lin 1990)(King and J.D. Beggs 1990). Noteworthy in this step is the requirement of 
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Spp2p for the binding of a free Prp2p to the spliceosome (Roy, K. Kim, Maddock, 
Anthony, and Jr 1995). After the Prp2p rearrangement, the NTC-related factor Yju2 is 
thought to promote the first transesterification reaction of splicing (Yen-Chi Liu, Hsin-
Chou Chen, Nan-Ying Wu, and Soo-Chen Cheng 2007).  
4.1.2  The Assembled Spliceosome in Yeast versus Mammals 
While a large body of data has been generated from yeast, a number of 
biochemical studies have recently emerged from mammalian extracts. In so doing, a 
number of differences have been identified in the splicing machinery. Some of these 
basics were reviewed in chapter one of this dissertation. Some are reviewed below. 
Perhaps the largest difference between the mammalian splicing apparatus and that 
of Saccharomyces cerevisiae is in the lack of the alternative AT-AC spliceosome 
machinery in yeast (Woan-Yuh Tarn and Joan A. Steitz 1997). This system utilizes pre-
mRNA with non-canonical splice sites and relies on a different set of snRNPs with the 
exception of the shared U5 (Claudia Schneider, Cindy L Will, Olga V Makarova, Evgeny 
M Makarov, and Reinhard Lührmann 2002). This point is worth noting on a technical 
level, as a pulldown against any U5 component will result in a heterogeneous population 
in the mammalian system. There are no such complications in budding yeast.  
Nonetheless, many differences also exist between the canonical yeast and 
mammalian spliceosomes. Purified mammalian spliceosome have contained a number of 
proteins that have no known yeast counterpart (Appendix I). The reverse of this situation 
presents itself when analyzing yeast complexes. Generally speaking, these differences 
may represent species-specific function or simply result from uncharacterized trans-
acting factors. 
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4.1.3  tri-snRNP Formation and the Impact on the Spliceosome 
It is in the re-formation of the tri-snRNP that the catalytic core of the spliceosome 
is assembled. This particle is the combination of three snRNAs and 28 proteins (S. W. 
Stevens et al. 2001). After the splicing cycle is complete, Prp24p aids the reannealing of 
free U4 to U6 snRNA to form the U4/U6 di-snRNP (Raghunathan and C. Guthrie 1998a). 
This particle associates with the U5 snRNP to form the U4/U6∙U5 tri-snRNP. The 
basepairing that brought together U4 and U6 continues to pair these RNAs in the tri-
snRNP. Unlike U4 and U6, however, U5 appears to be associated with the particle 
exclusively through protein-protein interactions. Previously, Prp6p was identified as a 
possible candidate (Galisson and Legrain 1993) for bridging U5 to U4/U6. Mutations in 
PRP6 reduced tri-snRNP formation while levels of the precursor U5 and U4/U6 snRNPs 
remained unaffected. We have recently confirmed this role of Prp6p through the SNU40 
and SNU66 deletions documented in Chapter 3. To summarize, Prp6p was shown to 
interact transiently with the U5 snRNP. This U5 interaction takes place via Snu40p, 
which ultimately coordinates the handoff of Prp6p to Snu66p during tri-snRNP 
formation. A deletion of both SNU40 and SNU66 results in the destabilization of Prp6p 
from the tri-snRNP and ultimately a defect in U4/U6 unwinding. The reduced ability of 
Brr2 to unwind U4 and U6 results in the observed cold sensitive phenotype. 
4.2 RESULTS 
4.2.1 Double Deletion Strains Accumulate PRP6 in a large particle. 
In chapter three, data was exhibited that the deletion of SNU40 and SNU66 resulted in 
decreased Brr2p unwinding of U4 from U6. Given this fact, one could hypothesize that a 
stalled pre-catalytic spliceosome accumulates under restrictive conditions. Indeed, 
another look at the native gel analysis of Prp6p containing particles revealed that the 
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deletion of SNU66 resulted in the buildup of large complexes in whole cell extracts 
(Figure 4.1, a subset of the earlier Figure 3.6).  To review, cell extract was separated by 
native gel, transferred to a membrane and analyzed by western blot utilizing an antibody 
against the TAP tag affixed to Prp6p. In the strain containing both SNU40 and SNU66 the 
vast majority of Prp6 is contained in the U4/U6∙U5 complex at 19°C (Figure 4.1, lane 1). 
This pattern was also seen in the strain lacking SNU40 (Figure 4.1 lane 2). Nonetheless, 
when SNU66 is deleted from the strain, Prp6p is destabilized from the tri-snRNP. Further, 
Prp6p can be detected in a spliceosome sized complex. (Figure 4.1 lane 3). When both 
SNU40 and SNU66 are deleted, the resulting extract contains Prp6p almost exclusively in 




Figure 4.1 - ∆snu40/∆snu66 extracts contain Prp6p in large complexes  
 
Prp6p-TAP tagged strains created from the indicated SNU40 and SNU66 
genotypes were used in the creation of whole cell extract. These extracts were separated 
on a non-denaturing polyacrylamide gel and transferred to a nitrocellulose membrane. 
This membrane was then western blotted with a PAP antibody. The positions of 
spliceosome and U4/U6•U5 complexes are indicated while the predicted positions of the 
U4/U6 and U6 snRNPs are inferred.  
 94 
 
4.2.2 Purification of a large PRP6 containing complex 
The buildup of Prp6p in a spliceosome-sized complex provides an interesting 
target for purification and analysis. To this end, after harvesting cells previously 
temperature shifted to 19°C, we utilized the TAP tag on Prp6p for affinity purification. 
After cleavage from the IgG-sepharose column with Tobacco Etch Virus (TEV) protease, 
a glycerol gradient was used to separate the Prp6p-associated particles. After 
fractionation of the gradient, the samples were phenol-chloroform extracted and the 
nucleic acid-containing aqueous layer was separated from the protein containing organic 
layer. The subsequent aqueous fractions were then precipitated and analyzed by 
denaturing gel northern blot analysis with 
32
P-labeled oligonucleotide probes against U1, 
U2, U4, U5, and U6 snRNAs (Figure 4.2). Fractions 7-9 (~25S) contain tri-snRNP, and 
all five snRNAs were found in fractions 15-17. This position in the gradient corresponds 
to a size of ~55S.  It is also noteworthy that all five were found in a roughly equal 
stoichiometry. 
The protein content from each fraction in the glycerol gradient was also analyzed. 
After acetone precipitation, protein pellets were resuspended in LDS loading buffer and 
resolved on a denaturing Bis-Tris gel. A number of protein bands can be observed in the 
lanes determined to contain U4/U6∙U5 (Figure 4.3 lanes 7-9) as well as all five snRNAs 
(Figure 4.3 lanes 15-17). 
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Figure 4.2 – All five snRNAs are found in a 55S complex 
All five snRNAs are found in a ~55S sized complex in a temperature shifted 
∆snu40/∆snu66 extract following PRP6-TAP affinity purification. Following dialysis to 
50mM NaCl, whole cell extract was affinity purified by IgG-Sepharose and TEV elution. 
Eluate was placed on a 10%-30% glycerol gradient, fractionated, and the RNA was 
precipitated. Odd numbered fractions were run on a denaturing gel. Northern blot 
analysis using probes against all five snRNAs indicate the presence of all of these 




Figure 4.3 – A protein complex is identified to migrate at 55S  
Proteins were precipitated from the fractions collected in Figure 4.2. A 4%-12% 
BIS-TRIS gel separated proteins, which were then visualized by Coomassie stain.
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4.2.3 U6 is exclusively base paired with U4. 
4.2.3.1 Native RNA Analysis 
Previous work has shown that U6 undergoes numerous rearrangements 
throughout the splicing cycle. The basepairing of U4/U6 in the context of all five 
snRNAs is one of the defining characteristics of the pre-catalytic A2-1 spliceosome.  To 
examine this basepairing status we employed two different methods. The first was to 
examine RNA from the purified particle under native conditions. The second examined 
psoralen crosslinked RNA. RNA analysis was ultimately performed by northern blotting 
with probes for U2, U4, and U6. Pooled glycerol gradient material (Fractions 15-19) 
identical to that prepared in the previous section was used. 
The native gel analysis required use of both a native control as well as one 
prepared under denaturing conditions. The first control lane (Figure 4.4) indicates the size 
of a denatured, and therefore un-basepaired, mono-U6 snRNA. The second control lane, 
prepared under native conditions, exhibits the presence of both basepaired and mono-U6 
snRNA. In the third lane, the RNA from purified spliceosome indicates that fully 100% 
of the U6 snRNA is base-paired with a partner snRNA. While this assay identified the 
base pairing status of U6, the snRNA that formed the other half of that pairing remained 
unknown. As described above, U6 is found base-paired with U4 in the snRNPs and in the 




Figure 4.4 - 100% of the U6 snRNA is base paired in purified particle 
The first two lanes are controls that identify the migration rate of a base paired or 
denatured U6 snRNA. The first lane consists of whole cell RNA prepared under 
denaturing conditions, while the second lane contains whole cell RNA prepared under 
denaturing conditions. The third lane contains 55S glycerol gradient material after phenol 
chloroform extraction and a gel load under native conditions. After transfer to a 
membrane, the sample was probed for the U6 snRNA. These results indicate that the U6 
snRNA contained in the particle is exclusively base paired with a single species. 
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4.2.3.2 Psoralen Crosslinking of RNA 
To identify any possible U2/U6 or U4/U6 base pairing, the same glycerol gradient 
material used previously in section 4.2.3.1 was employed.  The RNAs were crosslinked 
by addition of psoralen and application of UV light (K.M. Wassarman and J.A. Steitz 
1993). After phenol chloroform extraction and ethanol precipitation, the RNA was 
resuspended, split, and run in three identical lanes under denaturing conditions. This gel 
was then cut into slices and transferred onto three different membranes which were then 
probed for either the U2, U4, or U6 snRNAs (Figure 4.5). While U2 was bound to a large 
complex contained near the well, U4 and U6 co-migrated to identical positions on the gel. 




Figure 4.5 - Crosslinked RNA reveal U4-U6 basepairing 
Psoralen crosslinking of purified particle reveals U4-U6 base pairing and not U2-
U6. 55S sized glycerol gradient material was crosslinked with Psoralen and run on a 
denaturing gel. The gel was split and transferred to multiple membranes that were in turn 
individually probed for U2, U4, and U6. 
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4.2.4 Pre-mRNA Status in the Active Complex  
Previous work (Scott W. Stevens et al. 2002) indicated that all five snRNAs can 
exist in the absence of a substrate pre-mRNA. Thus, in order to confirm or reject this 
complex as the A2-1 pre-catalytic spliceosome, the presence or absence of pre-mRNA 
was tested. Given the extremely low quantity of any single species of pre-mRNA, 
selecting an assay with adequate sensitivity was a concern. In response, RT-PCR was 
used to confirm the status of three separate transcripts: RPS4A, RPS10A, and RPL16A. 
To prepare the RNA for the reaction, proteinase-K treatment was utilized to rid the post-
glycerol gradient particle of all protein components. The remaining RNA was then 
phenol–chloroform extracted followed by ethanol precipitation. Figure 4.6 contains 
complete data on RPS4A while RPS10A and RPL16A data is summarized in Figure 4.7 
The results (Figure 4.6) of the RPS4 RT-PCR reveal that both pre-mRNA and 
mature mRNA are present. Utilizing primers on both exons of RPS4 results in the 
identification of full pre-mRNA and as well as the shorter spliced mature mRNA (Figure 
4.6 Lane 1). A second primer set, directed against the intron and second exon (Figure 4.6 
Lane 2) also resulted in the appropriate sequence length thus confirming the presence of 
unspliced and/or intermediate transcript. Later sequencing of these DNA bands 
confirmed the presumed identities. It is noteworthy that a significant amount of mature 
mRNA is carried in the purified particle, presumably as an external contaminant (see 
discussion for elaboration). In any event, the presence of pre-mRNA within the context 
the spliceosome defines the presence of an A2-1 complex.  
We then tested the particle for catalytic activity. Splicing reactions were set up in 
the presence of either wildtype cellular extract (Figure 4.6 Lane 3-4) or RNA-free 
micrococcal nuclease treated wildtype extract (Figure 4.6 Lane 7-8). Micrococcal 
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nuclease treatment was executed as described earlier in section 2.6.16 and later in 4.2.5.1. 
While the introduction of the extract provides factors required for splicing, the 
introduction of exogenous RNA introduces the possibility that pre-mRNA is spliced by 
these external players. Additionally, the introduction of additional pre-mRNA or mRNA 
species could complicate the analysis of the assay results.  To prevent any of these issues 
extract was nuclease treated prior to introduction to the assay.  
Controls for these extracts were run to probe our assay‟s sensitivity to pre-mRNA 
and mRNA introduced. Extract (Lane 5-6) and nuclease treated extract (Lane 9-10) was 
tested in the absence of the purified particle. A lack of detectable pre-mRNA and mRNA 
was observed in both cases. 
Overall, the results from this semi-quantitative RT-PCR were plotted for each 
species (pre-mRNA, intron, and mRNA) as a percentage of total sample RNA (Figure 4.6 
bottom). Note that the „intron‟ primer set anneals to the pre-mRNA as well as 
intermediate species and therefore represents a mix of both. The results show that the 
RPS4A pre-mRNA is reduced with the addition of wildtype cellular extract. The 
magnitude of this reduction is moderated in the presence of nuclease treated extract. 
While corresponding increases in the levels of mature mRNA are observed, the levels of 
the „intron‟ species seem steady or to rise throughout. Given the decrease in the full 
length pre-mRNA species (Exon1-Exon2 Large), the lack of a corresponding decrease in 





Figure 4.6 - RT-PCR of RPS4 confirms the presence of mRNA 
RT-PCR analysis of particle exhibits the presence of both pre-mRNA and mature 
mRNA. 55S sized glycerol gradient material was proteinase K treated, phenol-chloroform 
extracted, and ethanol precipitated. Any RNA present was used as a template in an RT-
PCR reaction. The reaction product was analyzed by agarose gel. The first experimental 
lane contains the results using a primer set against both exons in the respective gene. 
Thus, the larger band represents unspliced pre-mRNA while the lower molecular weight 
band represents mature mRNA. The second experimental lane contains data resulting 
from a primer set directed against the intron as well as 3‟ exon. Thus, the presence of a 
single band confirms the presence of a mix of pre-mRNA and blocked lariat intermediate. 
 104 
The analysis of the other two transcripts, RPS10A and RPL16A, resulted in the 
same general pattern seen for RPS4A in Figure 4.6. For simplicity, analysis of all three 
transcripts is presented in Figure 4.7. These plots consider mRNA content within the 
particle itself along with the changes introduced by the nuclease treated extract. In all 
cases, the band intensity corresponding to the pre-mRNA falls relative to the mature 
mRNA. Nevertheless, the primer set annealing to the intron and second exon either gains 
in intensity (RPS4A) or remains roughly static (RPS10A, RPL16A, data not shown). 
Overall, the behavior of the intron-exon two primer set RT-PCR results indicate a 














Figure 4.7 – RPS4A, RPS10A, and RPL16 splicing efficiency 
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4.2.5 Recycling of the A2-1 Complex  
4.2.5.1 Micrococcal Nuclease Treatment 
In order to assess the vitality of the purified A2-1 complex through multiple 
rounds of activity, we tested the particle‟s ability to splice an exogenous mRNA species. 
The capability of the particle to restore splicing activity to an extract depleted of RNA via 
micrococcal nuclease indicates that the A2-1 complex is viable for successful recovery 
and reuse. 
We prepared a splicing-competent extract using methods (Ansari and Schwer 
1995) similar to that employed earlier in affinity purification. This extract was then 
treated as has been described elsewhere (Yean and R.J. Lin 1991) with micrococcal 
nuclease to degrade all RNA at hand. The nuclease activity was later quenched through 
chelation of calcium ions by addition of EGTA.  Northern blot analysis confirmed the 




Figure 4.8 - Nuclease degradation of snRNAs 
Micrococcal nuclease treatment results in obliterated snRNAs in whole cell 
extract. Whole cell extract was treated with micrococcal nuclease to degrade any RNA 
present. Northern blot analysis confirms the successful degradation of all five snRNAs. 
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4.2.5.2 Splicing Reaction 
Upon EGTA chelation of the nuclease reaction, this extract was used in a series of 
splicing reactions (R.J. Lin, Newman, S.C. Cheng, and J. Abelson 1985). The intent of 
these reactions was to detect the splicing of an in vitro transcribed and radiolabeled pre-
mRNA.  Negative controls consisted of pre-mRNA only (Figure 4.9, lane 1) and pre-
mRNA added to the extract prior to nuclease treatment (Figure 4.9, lane 2). The latter of 
these controls was intended as an additional method of assessing the success of 
micrococcal nuclease digestion of the RNAs present. Positive controls included a non-
nuclease treated extract (Figure 4.9, lane 3) as well as a non-nuclease treated extract plus 
purified particle. Among the reactions that used nuclease treated extract, lane 8 served as 
the negative splicing control as it contained no A2-1 complex. Lanes 5-7 contained 
increasing amounts of purified A2-1 particle along with nuclease treated extract. (1µl 
particle in lane 5, 2µl in lane 6, and 4µl in lane 7). 
Increasing amounts of purified A2-1 complex resulted in increasing levels of 
splicing while the control reaction exclusively containing nuclease treated extract 
exhibited no activity (Lane 8). When analyzed by quantitative software analysis, it can be 
seen that increasing the volume of purified particle in a splicing reaction from 1µl to 4µl 
increased levels of spliced mRNA from 17% to 22%, respectively (Figure 4.10). These 
data can be benchmarked against a non-nuclease treated control reaction (Figure 4.9, 
Lane 3) which shows 53% of the total RNA being processed to mRNA (Figure 4.10). The 
addition of 4µl particle (Figure 4.9, Lane 4) to this control has negligible effect with 49% 
mRNA produced (Figure 4.10). In contrast to the splicing activity of the in vivo 
assembled spliceosome, the recycled splicing complex shows no second step block 




Figure 4.9 – A2-1 complex snRNA recycling 
Splicing reactions exhibit catalytic activity of the purified A2-1 complex. Splicing 
reactions were carried out in the presence of wildtype whole cell extract (lane 1), 
wildtype extract plus 4µl purified A2-1 particle (lane 2), and increasing volumes of A2-1 
complex in micrococcal nuclease treated extract (lanes 3-5). Lane 6 demonstrates the lack 
of catalytic activity when micrococcal nuclease treated extract is used in the absence of 




Figure 4.10 - Increasing particle results in increased mRNA splicing 
Quantitation of bands in Figure 4.9 Lanes 3-7.  Exon 1 bands resulting from a 2nd 
step block were not detectable in amounts sufficient for quantitation.
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4.2.6 Three Step Purification Reduces Contamination 
The final step in the project led us to submit the peak protein fraction (Figure 4.3, 
Fraction 17) to mass spectrometric analysis (as described in section 2.6.8). The results 
(data not shown) of this analysis unfortunately indicated a high level of ribosomal 
contamination. To further reduce nonspecific interactions in the purified particle, a third 
stage was added to the purification. This step utilized the calmodulin binding domain of 
the TAP tagged Prp6p. In brief, the peak glycerol gradient fractions of 15-19 were pooled 
and applied to a column filled with calmodulin resin. A five fraction EGTA elution was 
followed by RNA extraction and ultimately northern blot analysis. This revealed that that 





Figure 4.10 - All five snRNAs are retained during a three-step purification 
Northern blot analysis of RNA fraction eluate during a two and three step 
purification. After the first IgG affinity step, the contents were placed on a glycerol 
gradient. The peak fractions from the gradient were pooled and a sample was saved for 
later analysis (Lane 1). The remainder of the material was loaded, washed, and eluted 
from a calmodulin column in five fractions (Lane 3-7). 
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4.2.7 Mass Spectrometric Analysis of RNP Complex 
In order to obtain adequate quantities of the particle for mass spectrometry, five 
IgG affinity purifications were performed in parallel. The eluate from each of these 
columns was sedimented through a glycerol gradient and fractionated. Based on the 
results shown in Figure 4.2, fractions 15 - 19 were pooled from each of the gradients. 
This material was loaded to five calmodulin columns in parallel. Upon elution from the 
column with EGTA, the material was phenol chloroform extracted and the organic layer 
acetone precipitated as in section 4.2.6. After pelleting any proteins present, the sample 
was submitted to mass spectrometric analysis undertaken with collaborators at the Yates 
lab at the Scripps Research Institute, CA. This analysis utilized a system termed 
Automated Ultra-High Pressure Multidimensional Protein Identification Technology 
(UHP-MudPIT) (Motoyama, Venable, Ruse, and John R Yates 2006) that relies on liquid 
chromatography to separate the single sample complex protein mixture prior to analysis. 
Examination of the data revealed that proteins from all five snRNPs were present, 









Table 4.1 - Results of mass spectrometry on the A2-1 complex 
Mass Spectrometry analysis of an affinity-purified 55S particle reveal proteins 
from all five snRNPs as well as the PRP19 complex. After IgG affinity purification 
followed by glycerol gradient separation, peak fractions were further purified via 
calmodulin affinity chromatography. Proteins from this column‟s eluate were precipitated 




As described in Chapter 3, cold-shifted Δsnu40+Δsnu66 double deletion strains 
exhibit a buildup of a spliceosome-sized particle containing Prp6p. The results revealed 
that Snu40p and Snu66p were responsible for the handoff of Prp6p from the U5 snRNP 
to the newly forming U4/U6∙U5 tri-snRNP. When SNU40 and SNU66 were deleted from 
the cell, the position of Prp6p in the tri-snRNP became destabilized. Additionally, Brr2p 
was greatly reduced in the ability to unwind U4 from U6.  
From these results, the identity of the large Prp6p containing complex could be 
inferred. Our hypothesis was that after tri-snRNP formation, the spliceosome was 
assembling typically. However, at reduced temperatures, the inability of Brr2p to unwind 
U4 from U6 would result in a stalled precatalytic (A2-1) complex. With this hypothesis 
in mind, we set about the purification of the particle in question. 
Initially we started the purification as a two step process. The first step involved a 
simple affinity purification via an IgG Sepharose interaction with a TAP-tagged Prp6p. 
This was followed by elution from the column by TEV protease and glycerol gradient 
separation of the resulting complexes. It is worth noting that in an attempt to retain 
condition similarity with the extract in which the particle was originally identified, the 
purification was performed under conditions typical (Ansari and Schwer 1995) to those 
used in splicing reactions. In short, care was taken to harvest the cells at 4°C with 
extensive washes. Cell disruption utilized a cryogenic ball mill, which disrupts cells in a 
manner similar to a mortar and pestle. After cell thawing and a high salt extraction phase, 
all lysate was adjusted to splicing-compatible 50 mM NaCl before proceeding with the 
purification. 
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The resulting material, when extracted and precipitated, revealed all five snRNAs 
to be present in a complex approximately 55S in size (Figure 4.2, fractions 15-19). 
Additionally, a significant amount of particle containing the U4, U5, and U6 snRNAs 
was seen in fractions 7-9. While this species may be the product of a native process, the 
relative lack of accumulated tri-snRNP seen in Figure 4.1 raises the alternate possibility 
that this is an experimental artifact resulting from destabilization of the larger particle 
found lower in the gradient.  
In addition to the snRNA composition, the base-pairing status of U2, U4, and U6 
aids in identifying the particle in question. Prior to spliceosome activation, U4 and U6 
remain extensively basepaired. Upon activation and progression from the A2-1 complex 
to the A1 complex U4 is unwound from U6 which then addresses the 5‟ splice site. U6 
snRNA concurrently forms a 11nt basepairing arrangement with the U2 snRNA (D.A. 
Wassarman and J.A. Steitz 1993). With these options in mind, we identified the status of 
these partners in the purified 55S complex. The first method used to determine 
basepairing endeavored to identify the base-pairing status of the U6 snRNA. Prior 
experience in the Stevens lab (unpublished data) indicates that phenol-chloroform 
extraction and ethanol precipitation of RNA is not does not perturb a paired U4/U6 
duplex. Separating the RNA from the 55S gradient fractions under native gel conditions 
followed by northern blotting for U6 revealed that 100% of the snRNA is in a basepaired 
state. This experiment was then repeated with the addition of a psoralen crosslinking 
technique. After crosslinking the particle, the RNA was extracted and precipitated. The 
sample was then split and separated under denaturing conditions on a urea-acrylamide 
gel.  Although the crosslinked RNA was run in three separate lanes, they were all run on 
the same gel thus assuring comparable migration rates. This gel was then dissected and 
transferred for northern blotting. The northern blot results revealed that the U2 snRNA 
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barely entered the gel, most likely due to a crosslink to the pre-mRNA and its large size. 
The co-migration of U4 and U6 indicate that they are crosslinked to each other and 
moreover are not crosslinked to the mRNA. Thus, the basepairing status of U4 and U6 
indicates the presence of an A2-1 complex. 
While previous work (Scott W. Stevens et al. 2002) in this lab indicated that all 
five snRNAs can be purified in the absence of a substrate pre-mRNA, the A2-1 complex 
exists in the presence of a substrate. To distinguish between these two possibilities we 
selected a few highly transcribed RNAs for analysis. RT-PCR of the RPS4A, RPS10A, 
and RPL10A transcripts indicate the presence of high amounts of pre-mRNA. With this, 
we are able to conclude with certainty that we have purified an A2-1 splicing complex.  
Although we have successfully identified this purified particle, it is formally 
possible that it was a nonfunctional dead-end product resulting from the deletion of 
SNU40 and SNU66. If the complex were simply stalled due to the U4/U6 unwinding 
defect at low temperatures there should be minimal effect on splicing once the particle is 
activated. Alternately, the deletions may have downstream effects on splicing that are 
independent of U4 and U6 unwinding. To distinguish between these hypotheses, we 
tested the purified particle by two different assays. The first approach was to assess the 
ability via RT-PCR of the A2-1 complex to complete splicing of its bound substrate. The 
second technique was intended to assess the ability of this complex and its components to 
recycle through multiple rounds of splicing. The second method utilized the traditional 
radiolabeled in vitro transcribed pre-mRNA splicing assay. 
 There are two theoretical advantages of the first listed approach in analyzing the 
splicing efficiency of the substrate pre-mRNA. The first advantage of this system results 
from the use of an in vivo assembled substrate. The second advantage is the ability to 
analyze differences and similarities in splicing efficiency between any number of 
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transcript species while in a defined in vitro setting. While our current sample size of 
three is obviously inadequate for large scale differential transcript analysis, future work 
will leverage this platform. Additionally it should be noted that the RT-PCR data 
exhibited in this dissertation is preliminary in nature. As such, the results seen here are 
semi-quantitative and will be followed with multiple replicates of real time RT-PCR 
analysis prior to publication. As is, we are reasonably able to conclude that our purified 
A2-1 complex is indeed capable of completing the splicing cycle when in the presence of 
exogenous protein factors. Lastly, it is noteworthy that an apparent increase in lariat 
intermediate species indicates that the particle may not function in this assay with upmost 
efficiency. 
Although the in vivo assembled particle appears to be deficient in progressing 
through the second step of splicing, it is a formal possibility that this defect is the result 
of either snRNA or protein component defects. To distinguish between these options we 
carried out a splicing reaction of exogenous in vitro pre-mRNA in a RNA free 
micrococcal nuclease treated extract. As spliceosome components are recycled they 
should readdress the freshly added pre-mRNA. Once recycled, however, the snRNAs 
should be complimented with the complete set of splicing proteins.  
As increasing amounts of the particle were added to the reaction we observed that 
correspondingly increasing amounts of mature mRNA product was being produced. 
Quantitation analysis revealed that when additional volumes of particle were placed into 
the reaction, an increase in completed mRNA product as well as intermediate species 
could be observed. Thus, the snRNAs that were purified were indeed able to recycle 
through multiple rounds of splicing. 
Given the positive identification of this stalled A2-1 complex and subsequent 
assessment of its catalytic viability, the obvious remaining challenge was to identify the 
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components of this complex. We were fortunate to have willing collaborators in the Yates 
lab at the Scripps Research Institute. Their expertise and highly sensitive equipment 
made analysis of the protein components by mass spectrometry an efficient process. 
The coomassie stained gel of the glycerol gradient fractions (Figure 4.3) revealed 
numerous proteins present in the fractions corresponding with those containing snRNAs. 
When the protein fractions of the 55S complex were examined by mass spectrometry, 
however, they revealed a high level of background contamination. To reduce these 
contaminants, future gradient material was passed over a second affinity column, this 
time utilizing the calmodulin binding domain of the TAP tag. Combined with a final high 
salt (250 mM) wash while on the calmodulin column, the results were far superior to 
earlier attempts.  
The mass spectrometry analysis revealed that components from all five snRNPs 
were present. 94% (16/17) of established U1 proteins were found, along with 85% 
(17/20) of known U2 proteins.  Of the core tri-snRNP proteins, 82% (23/28) were found 
in the particle. Additionally, all eight members of the Prp19p associated complex 
(NineTeen Complex, NTC) were identified. Most of the members of the Sm and Lsm 
class were identified, with the exception of Lsm3 and SmE. Other proteins of interest that 
were identified in the complex were Spp2, Prp2, and Yju2.   
 The characterization of a stalled A2-1 complex sheds significant light on the 
assembly of the Prp19p related complex (Chun-Hong Chen et al. 2002) and associated 
members. Not only are the functions of this complex still being elucidated, but it remains 
unclear at what stage the components join the spliceosome. Previous work (Chan, Der-I 
Kao, Wei-Yu Tsai, and Soo-Chen Cheng 2003) (Chan and Soo-Chen Cheng 2005) 
indicates that the NTC is required for stable association of U5 and U6 in the post-U4 
spliceosome. Additional work suggested that the NTC joined the spliceosome near the 
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time of U4 disassociation while remaining noncommittal as to the specific order of these 
events (Chun-Hong Chen et al. 2002). The presence of the complete NTC in a stalled A2-
1 complex in this dataset, solves this quandary.   
The DEAH box helicase Prp2p is responsible for the rearrangements required for 
the first transesterification reaction of splicing (S.H. Kim and R.J. Lin 1993). Spp2p is 
established as interacting with the spliceosome prior to the joining of Prp2p (Roy, K. 
Kim, Maddock, Anthony, and Jr 1995). Further, Spp2p interaction with the C-terminus of 
Prp2 is required for the helicase‟s activity (Silverman et al. 2004). In spite of what is 
known about these proteins, it remains unknown when exactly they join the spliceosome. 
Based on the results here, it can be concluded that Spp2p and Prp2p join the spliceosome 
prior to activation. Of the three other proteins shown to interact with Prp2p (Cef1 (Gavin 
et al. 2002), Cin2 (Ito, Chiba, Ozawa, Yoshida, Masahira Hattori, and Yoshiyuki Sakaki 
2001), Brr2p (van Nues and Jean D. Beggs 2001)) two of them (Cef1, Brr2) were isolated 
in the A2-1 complex. 
The NTC associated Yju2p has been shown to function after the Prp2-dependent 
spliceosomal rearrangement to promote the first step of splicing (Yen-Chi Liu, Hsin-
Chou Chen, Nan-Ying Wu, and Soo-Chen Cheng 2007). While it is known when Yju2p 
acts in the splicing cycle, it is unknown when it joins the complex. Competing theories 
exist that place Yju2p in the spliceosome with the NTC or alternately after activation (A1 
complex formation). Our data demonstrate that Yju2p has indeed joined the spliceosome 
prior to A2-1 complex formation. 
Although fewer data points on spliceosome function have been gathered in the 
mammalian system, it is notable that the counterpart of the A2-1 complex has recently 
been characterized (Deckert, Hartmuth, Boehringer, Behzadnia, Cindy L. Will, Berthold 
Kastner, Holger Stark, Henning Urlaub, and Reinhard Luhrmann 2006). Known as the B 
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complex, the precatalytic mammalian spliceosome is also the only snRNP complex 
known to contain all five snRNAs in the presence of a substrate pre-mRNA. 
Complicating the comparison of these two datasets, however, are two issues. The first 
issue is that of missing homologs. As there are significant evolutionary differences 
between these species, differences in protein content and function are to be expected in 
spite of the generally high level of conservation in the core spliceosomal machinery. The 
second complicating factor in comparing data sets is that of naming convention. For a 
variety of reasons homologous proteins differ in name between these two species. To aid 
in the comparison of the Saccharomyces cerevisiae and human datasets, a translation 
table of proteins known to be of importance in splicing. It is included in Appendix I. 
Overall, the two datasets show a high degree of alignment (Appendix II). There 
are a number of proteins found in the Saccharomyces cerevisiae spliceosome that have no 
known homolog in the mammalian system. Ignoring these differences, there are only 
three proteins found in our core spliceosome dataset (Table 1.1) that was are not also 
confirmed by the mammalian data (Snu17p, Prp4p, Lsm3) (Detail in Appendix II). The 
comparison of identified mRNA binding proteins as well as splicing associated factors 
has a less complete overlap, however, with 24 proteins remaining unconfirmed by the 
between the two datasets.  
As pointed out elsewhere (Maria M Konarska 2008), what was considered to be 
the B complex in this work (Deckert et al. 2006) is actually the combination of at least 
three different species. Criticism of this work has noted that this heterogeneity may 
account for the appearance of the mammalian NTC counterpart - as it was generally 
thought to join the spliceosome after the exit of U1 and U4. On the basis of U4/U6 
binding status and stoichiometric snRNA ratios, our data would not appear to suffer from 
this same heterogeneity. The A2-1 complex purified here is a mono species including all 
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five snRNAs that results from the Δsnu40 + Δsnu66 induced U4/U6 unwinding defect. 
The presence of contaminating mature mRNA would seem to complicate these findings, 
however. Given that the vast majority of cellular mRNA has already been spliced and the 
exquisite sensitivity of the RT-PCR assay, the presence of detectable levels of this 
contaminant is not surprising. It should be pointed out that the presence of this spliced 
product does not impact the RT-PCR data of the pre-mRNA nor of the intron-exon 2 
product. Further, in analyzing the splicing efficiency of the purified material, one can 
assume that the substrate RNA is conserved through the splicing process. Any analysis 
that tracks each species as a percentage of the total at any point in time will capture net 
migration regardless of the starting volumes. In any event, our data on the NTC remains 
particularly compelling when the mammalian B complex data is considered. Indeed, in 
combination with this information we are able to establish that the NTC and related 
factors are present in the spliceosome prior to the unwinding of U4 and U6. 
In addition to the comparison of the A2-1 complex and the earlier mammalian B 
complex, Appendix II also includes a comparison with earlier data (Scott W. Stevens et 
al. 2002) on the penta-snRNP complex. It is the overall similarity that stands out in 
comparing the core components of the A2-1, B, and penta-snRNP complexes. Almost all 
of the core U1, U2, tri-snRNP and NTC proteins are present in the A2-1 / B complex and 
penta-snRNP. Some of the remaining differences are likely the result of peptide coverage 
issues. For example, the missing SmE in the A2-1 and B complexes is unlikely to be a 
true biological result. On the other hand, it is conceivable that some of the other 
differences represent actual differences between homologous species. It is difficult to 
predict which of these are worthy of further scrutiny, but the simple illumination of the 
variation is surely the first step of analysis. 
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In moving beyond the core snRNP proteins, true differences between the penta-
snRNP and A2-1/B complex stand out. Fifteen proteins identified as being associated 
with mRNA binding were identified in the A2-1 complex. Of these, almost half were 
identified in the B complex. In contrast, none were identified in the penta-snRNP. Of 
course this result is to be expected as the penta-snRNP lacks the substrate mRNA that 
carries these proteins.  
As discussed earlier, the NTC associated protein Yju2p was identified in the A2-1 
complex. This protein was not found in the penta-snRNP complex, nor was the 
mammalian counterpart (CCDC130) found in the B complex. A similar situation exists 
for Spp2p which was identified in A2-1 to the exclusion of the other two complexes. The 
A2-1 complex data stands in particular opposition to the B complex in this last case. 
Given that the B complex successfully identified the mammalian Prp2p homolog, the 
lack of the mammalian Spp2 (GPKOW) seems unexpected. As Spp2p is thought to join 
the spliceosome prior to its interaction with Prp2p, one would not expect Prp2p to be 
found exclusively. In contrast, both proteins were found in the A2-1 complex.  
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Data based on: (Berglund, Abovich, and Rosbash 1998; Libri, Graziani, Saguez, 
and Boulay 2001; Bell, Schreiner, Damianov, Ram Reddy, and Bindereif 2002; Zhi-Ren 
Liu 2002; Jurica and M.J. Moore 2002; Vincent, Q. Wang, Jay, Hobbs, and B.C. Rymond 
2003; Qiang Wang and Brian C Rymond 2003; Sunbin Liu 2005; Lesley Collins and 
Penny 2005; Benson, Karsch-Mizrachi, Lipman, Ostell, and David L Wheeler 2006; 
Deckert et al. 2006) 
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APPENDIX II – PROTEINS OF THE A2-1, PENTA-SNRNP, AND 
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